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EmrE, an E. coli small multidrug resistance transporter, effluxes a diverse range of toxic 
polyaromatic cations, thus imparting resistance to drug compounds of this type.  Transporters 
must interconvert between inward- and outward-facing structures during the transport cycle to 
alternate access of its binding site between the two sides of the membrane.  As a secondary 
active antiporter, EmrE must couple drug binding to this conformational exchange and its energy 
source, the proton gradient across the inner membrane.  The transport cycle involves the import 
of two protons to drive the export of one substrate molecule. As a multidrug resistance 
transporter, EmrE has particularly broad specificity and a large variation in affinities for these 
transported substrates, yet all substrates must trigger the same conformational change between 
inward- and outward-facing states in order for transport to occur.  My research focuses on this 
coupling between substrate binding and conformational exchange and the functional outcome of 
this coupling, transport. 
As one of the smallest transporters, EmrE serves as an ideal system to study the minimal 
requirements for multidrug recognition and transport.  EmrE transports polyaromatic cations that 
xi
vary in geometry (i.e. planar vs. tetrahedral), charge (i.e. +1 vs. +2), and overall size.  By 
combining a variety of biophysical techniques, I have investigated the thermodynamics and 
kinetics of broad substrate recognition and the conformational interconversion that it triggers.  In 
particular, I have focused on two ligand series: i) a series of related tetrahedral ligands with an 
identical charge of +1, and ii) a series of planar ligands that vary in size and charge.  EmrE binds 
these substrates with affinities that span several orders of magnitude and transports them with 
varying efficiency.  We have directly monitored conformational exchange in substrate-bound 
EmrE using ZZ-exchange NMR spectroscopy and found that the rate of this key step in transport 
varies considerably with the identity of the bound ligand.  These studies have interesting 
implications for the energetics of the transport cycle.  Substrate binding alters both the ground 
and transition state energies of EmrE.  A common theme has emerged in the literature suggesting 
that enzymes pre-sample their functional motions in the absence of substrate.  However, to be a 
functional antiporter, EmrE cannot interconvert in the absence of substrate.  Thus, the protein 
alone cannot determine the barrier to exchange between the inward- and outward-facing states, 
and substrate must play an important role. 
xii
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Chapter I.  Introduction: The small multidrug resistance transporter EmrE. 
 
 Drug resistance, especially multidrug resistance, is a significant challenge to global 
health1,2.  The main mechanisms of drug resistance include modification of the target protein, 
metabolism of the drug, and decrease in drug uptake, either through decreased permeability or 
through active efflux1,3.  Multidrug resistance (MDR) transporters fit into this last category and 
play an essential role in the development of some forms of clinical drug resistance, especially 
multidrug resistance1.  To gain insight into the mechanism of multidrug efflux, I have focused 
my studies on the MDR transporter EmrE.  As one of the smallest known transporters, EmrE 
serves as an ideal system to study the minimal requirements for multidrug recognition and 
transport. 
 
Single-Site Alternating-Access Transport 
In order to efflux drug molecules from the cytoplasm, MDR transporters, as with most 
transporters, must move the substrate against its concentration gradient.  As a protein open to 
both sides of the membrane simultaneously would dissipate this gradient and in effect import 
drugs into the cell, the transporter must alternate the access of its binding site between the two 
sides of the membrane4.  In addition, these transporters must have an energy source to move 
these compounds against their concentration gradient, either the hydrolysis of ATP (primary 
active transport) or an ion gradient (secondary active transport).  Structures exist for MDR 
transporters of four different superfamilies: the ATP-binding cassette (ABC) family, driven by 
ATP hydrolysis, and the major facilitator superfamily (MFS), resistance-nodulation-division 
(RND), and small multidrug resistance (SMR) families, all driven by ion gradients1.  MDR 
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transporters must be able to tightly couple the binding of substrate to the conformational change 
and the energy source in order to perform active transport.   
Secondary active transporters use the downhill movement of an ion (H+ or Na+) as the 
driving force for the uphill movement of the substrate.  These transporters can either be 
symporters or antiporters, which move the substrate and driving-force ion across the membrane 
in the same or opposite directions, respectively.  These two types of transport have different 
mechanistic requirements within the alternating-access model5.  To carry out successful symport, 
a transporter must only undergo a conformational interconversion when bound to none or both of 
its substrates (Fig. 1A).  On the other hand, to carry out successful antiport, a transporter must be 
able to undergo its conformational interconversion when bound to either its substrate or the 
driving-force ion but not in its truly apo state (Fig. 1B).  This latter mechanism is also referred to 
as the single-site alternating-access model for transport. 
 
Multidrug Recognition 
Multidrug recognition evolved independently into the structural framework of a handful 
of different superfamilies of transporters in addition to the transcription factors that regulate their 
expression1.  The mechanism of multidrug recognition has intrigued researchers for decades.  
Most well-studied protein-ligand interactions involve highly specific recognition: a ligand with a 
well-defined chemical moiety binds in a well-defined protein cavity in a well-defined 
orientation.  But multidrug proteins recognize a wide range of chemically and structurally 
diverse compounds without being entirely nonspecific or promiscuous.  Each transporter or 
regulator does have a limit to which drug compounds it can bind, and transport activity can vary 
significantly between structurally related compounds, so there must be some form of 
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recognition6.  Are there common principles governing ligand recognition across the MDR 
transporters and MDR regulators? 
Limited structural studies have provided insight into the mechanism of multidrug 
recognition.  Due to the technical difficulties associated with structural investigations of 
membrane proteins, many important insights have been gained from the soluble MDR regulators 
in addition to studies of MDR transporters1,6,7.  The canonical MDR protein has a large, flexible 
binding pocket, with multiple subsites for coordinating different drugs7.  This is typified by the 
transcription factor QacR, which has been shown to bind different drugs, including proflavin and 
ethidium, at distinct subsites wherein the different compounds interact with distinct residues1.  
QacR can even accommodate these two ligands concurrently within the single, large pocket1,8 
(Fig. 2A).  The RND transporter AcrB has also been crystallized with multiple drugs.  These 
structures indicate that monocyline and doxorubicin bind in distinct but overlapping subsites 
(Fig. 2B)9.  Several members of the ABC and MFS transporter families have also been shown to 
be capable of binding multiple drug molecules simultaneously in different subsites1, offering 
additional support for the canonical view of MDR ligand recognition by a large, flexible binding 
pocket. 
Hydrophobic interactions and electrostatic interactions with active-site acidic residue(s), 
in addition to the architecture of the protein binding site and the structure of the small molecule, 
all play a role in the broad substrate specificity6.  There is a high content of aromatic residues in 
the binding pockets of MDR transporters and regulators.  These key residues are involved in π-
hydrophobic, π-π, and π-cationic interactions1,7.  Polar and charged residues are key in stabilizing 
drug charge and polar moieties.  Studies of QacR have revealed that the sidechains of these 
residues adopt different rotameric states depending upon the bound drug7. 
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Proteins that bind hydrophilic compounds must form specific hydrogen bonds and 
electrostatic and hydrophobic interactions in order for the small molecule to bind the protein 
preferentially over water, which in effect creates a highly specific binding site6.  On the other 
hand, there are fewer demands placed on a protein that needs to out-compete water for binding of 
a hydrophobic molecule6. 
 As described above, the canonical MDR transporter has a large, hydrophobic binding 
pocket with multiple, potentially overlapping, subsites1,6, but what about a small transporter?  As 
described in more detail below, the small multidrug resistance transporters, typified by EmrE, 
have a single, smaller binding site.  How can a single small protein accommodate a wide range 
of ligands in its binding pocket and transport them all? 
 
EmrE, an E. coli Small Multidrug Resistance Transporter 
EmrE is a representative member of the small multidrug resistance (SMR) family of 
transporters.  This family comprises the smallest multidrug transporters, and its members are 
found only in prokaryotes1.  SMR transporters have 100-140 amino acids that form four 
transmembrane (TM) helices connected by short loops and lacking any significant 
extramembrane domains1,10.  Members of this family have minimal functional units of dimers 
and form either homo- or heterodimers.  SMRs provide resistance to quaternary ammonia 
compounds and other lipophilic cations10. 
EmrE is a homodimeric SMR that is native to E. coli and exploits the proton gradient 
across the inner membrane to drive efflux of polyaromatic cations via the single-site alternating-
access model for transport11.  These substrates span a range of traits: they can be +1- or +2-
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charged, planar or tetrahedral, and a range of overall sizes.  The transport stoichiometry is 2 H+:1 
drug molecule stoichiometry, regardless of ligand charge12. 
Biochemical studies have determined the functional relevance of many key residues in 
EmrE (Fig. 3).  An active site glutamate is essential for transport function.  Glu14, located in 
TM1, is the only one of eight charged residues to be located within the transmembrane domain 
and is conserved across all SMRs.  E14D is the only mutant of this critical residue that is known 
to retain any function, and it has highly compromised activity11.  This membrane-imbedded 
glutamate has a highly elevated pKa, variously estimated to lie between 7.3 and 8.513-15, which 
poises proton binding and release around physiological pH.  TM1 contains a handful of other 
residues on the same helical face as Glu14 that are key in substrate binding and transport.  The 
residues Leu7, Ala10, Ile11, Gly17, and Thr18 are important in binding, and Ala10 is also 
important in coupling proton and drug transport11.  Aromatic residues are also important for 
substrate binding.  They are thought to stabilize substrate interactions by stacking with aromatic 
regions of the drugs and through cation/π interactions11. Trp63, Tyr40, and Tyr 60 are key 
aromatic residues for the binding of substrate, and Tyr4 is important in proton-drug coupling in 
transport11. 
As previously mentioned, the minimal functional unit of EmrE is a dimer, which is 
supported by a variety of biochemical experiments11.  A glycine motif in TM4 is essential for 
dimerization.  Gly90 and Gly97 are separated by six non-glycine residues, forming a GG7 motif.  
Within this motif, residues 93 and 94 are large hydrophobic amino acids in most SMRs, 
including EmrE.  This GG7 motif is instrumental in forming contacts between the two 
monomers11,16. 
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Structural Studies of EmrE 
 The existing structures for EmrE are of only medium resolution.  The first structure of 
EmrE was determined bound to TPP+ using electron cryomicroscopy (cryo-EM), with a 
resolution of 7.5 Å in the plane of the membrane bilayer and 16 Å perpendicular to the bilayer 
plane17,18.  A 3.8 Å x-ray crystal structure of TPP+-bound EmrE overlays well with the cryo-EM 
density map19 (Fig. 4A,C).  EmrE was crystallized in nonylglucoside for the x-ray crystal 
structure, but EmrE solubilized in this detergent has compromised activity.  The binding affinity 
for TPP+ is weakened by an order of magnitude when compared with the DDM-solubilized 
reference state19.  On the other hand, the cryo-EM structure was determined in a crystalline 
DMPC bilayer, which binds substrate properly20.  For this reason, despite its low resolution, the 
cryo-EM structure is considered the “gold-standard” for the EmrE structure21,22.   
Fleishman, et al. computationally designed a Cα model of the transmembrane region of 
EmrE based on the cryo-EM data and sequence conservation data (Fig. 4B)23.  The individual 
amino acids were not resolved in the cryo-EM structure, nor could the TM helices be assigned 
ambiguously.  However, Fleishman, et al. used the quasi symmetry relationship between six of 
the eight TM helices of the dimer, along with the single connection between two TM helices 
apparent in the cryo-EM density map and the spatial positions of the eight helices.  They 
combined these features of the cryo-EM structure with evolutionary conservation, i.e. that 
conserved residues are buried in the protein core while variable positions are exposed to lipid, in 
order to predict a Cα structural model23.   
The structure determined via x-ray crystallography is strikingly similar to the Fleishman 
computational model, as shown by the 1.4 Å average rmsd over equivalent Cα 19.  From both 
structures, it is clear that EmrE crystalized as an asymmetric homodimer, with six 
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transmembrane (TM) helices forming the substrate binding pocket and the remaining two helices 
forming a dimerization arm17-19.  13C chemical shift data from solid state NMR studies indicates 
that the active site residue Glu14 has two sets of peaks, supporting this structural asymmetry24.  
Although the topology could not be determined from the cryo-EM structure with certainty, the 
only symmetry relationship in that data is the pseudo-two-fold rotation axis in the bilayer plane, 
which implies an antiparallel dimer17.  Three TM helices from each monomer overlay well with 
each other after a 160° rotation about this pseudo-two-fold axis of symmetry.  The two TM 
helices that form the dimerization arm have a 20° tilt at this point18,22.  The x-ray crystal structure 
showed clear electron density for the loops connecting the four helices in each monomer.  In 
addition, selenomethionine labeling confirmed an antiparallel topology, as the positions of the 
labels on the two monomers were related by a pseudo two-fold rotation axis19. 
Although the majority of the side chains were not resolved in the x-ray crystal structure, 
the position of the backbone places biochemically important residues in the active site19.  The 
structure of the dimer showed that it allowed access to substrate from either one water-exposed 
face of the protein or the membrane leaflet on the same side of the bilayer while shutting off 
access to the other leaflet17, suggesting that EmrE was captured in the open-in or open-out state 
of the alternating-access mechanism.  
 The model proposed by Fleishman, et al. suggests a mechanism of conformational 
interconversion.  The two monomers swap conformations upon conversion of the dimer from the 
inward- to outward-facing structure.  In this model, the open-in and open-out states are identical 
structures that differ only in which side of the membrane they are open to.  These two states are 
related by a 180° rotation around an axis in the plane of the membrane bilayer.  During exchange 
between open-in and open-out states, TM1-TM3 from the two monomers move as a single unit.  
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On the other hand, the two TM4s form a stable pair, stabilized in part by G90 and G97 packing, 
and do not appear to move much during the conformational exchange.  The interface between 
TM3 and TM4, representing the connection between the substrate binding pocket and 
translocation pathway and the dimerization arm, is smaller than the other helix-helix interactions.  
The crossing-angles between TM3 and TM4 change by approximately 20° upon conformational 
interconversion as TM3 alternates between a kinked and straightened structure.  There is a small 
translation of the TM1-TM3 bundle with respect to TM4 between the two states.  As keenly 
noted by Fleishman, et al., the dual topology of EmrE has distinct advantages for transport 
mechanism.  Dual topology allows the open-in and open-out structures to be identical, which 
requires the evolution of only a single optimized low energy structure23. 
 Attempts have also been made to acquire structural information on drug-free forms of 
EmrE.  2D crystals in DMPC for cryo-EM studies were obtained for both drug-free and TPP+-
bound forms of EmrE, but the crystals formed in the presence of substrate were more highly 
ordered17.  The cryo-EM 2D projection map is very similar in the presence and absence of TPP+ 
17,25 and suggests that binding of drug results in movement of at least one helix25.  However, 
there is not a full 3D cryo-EM structure for drug-free EmrE.  The only full structure for a drug-
free form of EmrE is a 4.5 Å x-ray crystal structure that is widely considered to be non-
physiological (Fig. 4D)19,22.  This structure was acquired on EmrE that was crystallized in 
nonylglucoside at pH 4.  The protein is thought to be acid-denatured, but still has 4TM helices 
per monomer.  TM1-TM3 form a three helix bundle, which packs with the three-helix bundle 
from a second monomer.  However, TM4 lies within the bilayer plane rather than passing 
through it19.  As this helix forms the bulk of the crystal contacts in the eight-monomer 
asymmetric unit, it is still seen as an indication that TM4 is the key player in dimerization22. 
8
EPR studies were carried out to investigate the structure and dynamics of both the drug-
free and TPP+-bound forms of EmrE in a full lipid bilayer26.  Spin labels were systematically 
placed on each residue in the protein using single cysteine mutants to assess spin label dynamics, 
lipid and water accessibility, and pairwise short range distances.  The periodicity in the 
accessibility data supports four TM helices per monomer, and dipolar coupling between spin 
labels within the dimer support the packing of TM1-TM3 from each monomer, as seen in the 
crystal structures.  However, the data is not consistent with tight packing between TM4s, which 
is thought to be the driving force for dimerization.  The EPR data indicates that the drug-free 
state is highly dynamic with at least two spin label populations, one that is consistent with an 
antiparallel dimer.  This TPP+-free state was identified as the protonated form, but with samples 
collected at pH 7.5, it was likely to be a mixture of protonated and deprotonated EmrE.  Perhaps 
this mixture accounts for the two observed populations.  Nevertheless, the flexibility in the drug-
free state supports that idea that a dynamic apo state may contribute to broad ligand specificity.  
The EPR data indicates that, upon binding TPP+, EmrE undergoes conformational changes 
including a repacking of TM1, a tilting of TM2, and changes in the backbone of TM3 and the 
TM3-TM4 loop.  No significant changes were observed in TM4, which is consistent with the 
idea that ligand does not interact directly with TM4.  In addition, the EPR data is consistent with 
a kink in TM3, as observed in the x-ray crystal structure and Fleishman’s model.  Despite the 
general agreement with some of the broad structural features of the crystal structure, the EPR 
data has significant differences from the crystal structure of TPP+-bound EmrE, some of which 
might be explained by the low resolution of the crystal structure26. 
 Recently, an in vivo tryptophan scan was carried out to test features of the structures 
derived from EmrE crystallized out of membrane mimetic environments27.  Mutation of single 
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residues within the TM helices to bulky tryptophan side chains will perturb structure and 
negatively affect function if placed in a buried (rather than lipid-exposed) region of the protein.  
A total of 60 individual mutations were made across all four TM helices.  Tryptophan-scanning 
mutagenesis was accompanied by ethidium-resistance assays to assess function in vivo.  The 
functional results were in good agreement with lipid exposure determined from coarse-grained 
MD simulations based on the x-ray crystal structure.  All but one of the instances where the 
functional effects of the mutation did not correlate with lipid accessibility could be explained by 
location within the predicted structural and other biochemical data.  The results were not 
compatible with the only parallel structural model that has been published, which was based on 
sequence conservation and crosslinking data, because residues that were predicted to be essential 
for the dimer interface in the model are not affected by mutation to tryptophan27,28. 
 
Topology of the EmrE Dimer is Controversial 
 Although the existing structural data consistently suggests an antiparallel topology, the 
biochemical evidence has variously suggested parallel or antiparallel topology.  The concept of 
dual topology, or an antiparallel homodimer, is highly controversial, in part due to the 
implications for the synthesis and insertion of integral membrane proteins and membrane protein 
evolution. 
Several decades ago, von Heijne noted the bias for more positively charged residues 
(lysine and arginine) to be on interior loops and termini over exterior loops and termini and 
introduced the ‘positive-inside rule’29 for topology determination of integral membrane proteins.  
The von Heijne lab has explored the in vivo relation of topology to charge distribution in small 
bacterial membrane proteins, including SMRs, using the C-terminal fusion reporters GFP 
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(fluorescent in the cytoplasm) and PhoA (active in the periplasm).  Single charge mutations were 
shown to alter the reporter activity and thus the topology of predicted dual topology homodimers 
such as EmrE.  As a control, the paired gene SMR YdgE/YdgF, which has a strong and opposite 
charge bias between the two proteins, did not change topology with single charge mutations.  
Genes in the SMR family, as well as a few other families, occur as pairs in close proximity or 
singletons.  The paired genes have strong topological charge determinants, with the members of 
each pair biased for opposite orientations.  In contrast, the singletons do not have a strong charge 
bias, and thus likely have dual topology30. 
Ethidium resistance assays were carried out to investigate which topological forms of 
EmrE, created by altering the charge bias, are functional.  EmrE was mutated to change the K+R 
charge bias and form Nin-Cin and Nout-Cout forms.  Expressed alone, each charge-biased mutant 
no longer offered resistance to ethidium.  However, co-expression of the two mutants recovered 
resistance, suggesting that the engineered heterodimer formed a functional antiparallel dimer, but 
that each mutant alone was not capable of forming a functional unit31.  Even the addition of a 
single positively charged residue to various positions on EmrE can alter the topology32. 
Additionally, the Schuldiner lab has carried out various biochemical assays, such as 
crosslinking, tagging, and genetic fusions, to investigate the topology of EmrE.  Schuldiner has 
asserted that the biochemical equivalence of residues between the two monomers, indicated by 
the accessibility of active-site residue Glu14 and cysteines introduced in the TM region to 
chemical modification in the presence and absence of ligand, implies a parallel topology11.  To 
assess the topology in cells, membrane permeable and impermeable sulfhydryl reagents were 
added to cells expressing single-cysteine mutants of EmrE.  A cysteine-reactive fluorescent 
probe was then added to EmrE purified out of these samples to detect any unreacted cysteines.  
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These assays indicated that EmrE exits only in an Nin-Cin, and thus parallel, orientation33.  To 
assess functionality, purified EmrE crosslinked with o-PDM, which has a short linker and should 
only cross-link single-cysteine EmrE mutants if they have parallel topology, binds and transports 
substrate properly11.   
Genetically fused dimers were designed to force either a parallel or antiparallel dimer and 
allow the functionality of each topology to be tested.  Parallel fusions were made by inserting a 
short, hydrophilic linker between the C-terminus of the first repeat and the N-terminus of the 
second repeat.  Antiparallel fusions were designed by inserting a ninth TM helix (from 
glycophorin A) between the C-terminus of the first repeat and the N-terminus of the second 
repeat.  Both the parallel- and antiparallel-fused dimers transport monovalent and divalent 
substrates properly11,34.  To reconcile these mixed results, it has more recently even been 
proposed that EmrE can function as both a parallel, in both Nin-Cin and Nout-Cout forms, and 
antiparallel homodimer35.  Another recent paper has supported this claim that both parallel and 
antiparallel forms can exist, but that the antiparallel homodimer is more stable and is the 
functional form36.  It is difficult to envision how a protein can function in both topological forms, 
taking into account the location of the active site and dimerization residues.  The functionally 
relevant residues for ligand binding are on one face of the TM1-TM3 helices and TM4 is 
important in dimerization. 
Both sides of the topology debate can argue for lack of controls or misinterpretation of 
the biochemical data.  It is clear that EmrE topology is highly sensitive to exact sequence and 
likely also environment.  Thus, studies carried out on a mutant may not report on the native 
topology of EmrE and results may be skewed by the various C-terminal tags commonly used for 
expression or as topological reporters11,32.  In addition, the contradictory results arise from 
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experiments performed in different environments.  The topological investigations were carried 
out in vivo or on protein purified under different conditions and assayed in detergent or 
reconstituted into lipids.  It has been established that the structure and function of membrane 
proteins, including EmrE, are sensitive to environment37-39.  It is clear that more definitive 
experiments are required to clear up the topological controversy.   
 
Dynamics are Important in Protein Function 
 How do proteins involved in activities such as signaling and catalysis move between 
different functionally relevant structures, or conformations?  Structural techniques such as X-ray 
crystallography, cryo-EM, NMR, and small-angle X-ray scattering capture static structures or 
ensembles of static structures.  Adding ligands and changing solution conditions can capture 
alternative static structures.  These different structures may represent distinct low-energy 
conformational states along a functional pathway. The relative populations, or the relative free 
energies, of the conformational states describe the thermodynamics of the system, while the 
energetic barriers describe the kinetics of the system40.  Proteins that undergo large domain 
motions move, or exchange, between conformational states that are separated by energetic 
barriers of several kT.  These large domain motions occur on the timescale of microseconds-to-
seconds and are considered slow timescale motions (Fig. 5A).  This is the same timescale as 
most biological processes, and thus these motions may affect functional rates. Each 
conformational state is actually a collection of substates that are related by local flexibility, such 
as loop motions, side chain rotations, and bond vibrations.  Significantly smaller energetic 
barriers separate these substates, such that they occur much faster than the larger concerted 
motions, on the femtosecond-to-nanosecond timescales40.   
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NMR spectroscopy is an ideal technique for studying the kinetics of slow and fast 
timescale motions because it provides atomic resolution and can be carried out under native 
solution conditions at equilibrium.  Microsecond-to-second timescale motions are characterized 
by the NMR timescale of their exchange.  Practically speaking, the NMR timescale determines 
whether two peaks with intensities proportional to the relative populations of the two states (slow 
exchange), a single population-weighted peak (fast exchange), or something in between 
(intermediate exchange) is observed in a spectrum (Fig. 5B).  The NMR timescale is a 
comparison of the conformational exchange rate (the sum of the forward and reverse rates, kex) 
against the difference in the chemical shifts of the two states (∆!): !!" ≪ ∆! (slow exchange), !!" ≈ ∆! (intermediate exchange), or !!" ≫ ∆! (fast exchange).  
 My studies focused on the large domain motions necessary to alternate access of the 
EmrE binding pocket between the intracellular and extracellular sides of the membrane, which is 
the key motion for transport.  As this is a large domain motion, it falls into the millisecond-to-
second time regime that can be accessed via NMR experiments such as relaxation dispersion and 
ZZ-exchange spectroscopy, depending on the exact timescale of the dynamics.  As will be 
described in Chapters 3 and 4 in more detail, ZZ-exchange spectroscopy was the primary 
technique used to measure the rate of conformational exchange in ligand-bound EmrE. 
ZZ-exchange spectroscopy is used to quantify the rate of two-state exchange occurring on 
the millisecond-to-second timescale when two peaks are observed in the spectrum41-43.  For two-
state exchange between arbitrary states A and B, the system can be represented by the simple 
reaction scheme !!!"⟺!!"!.  In the ZZ-exchange experiment, magnetization is initially transferred 
from the amide 1H to the attached 15N, and the amide nitrogen chemical shift is recorded.  A 
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variable-time delay is inserted before transfer of magnetization back to 1H, and the chemical shift 
of the attached proton is then recorded (Fig. 6A,C).  During the variable-time delay, 
magnetization is stored as in-phase magnetization along z (i.e. parallel to the magnetic field)41 so 
that it is only subject to the slower longitudinal (T1) relaxation.  This permits extended mixing 
times to be used for the measurement of slow dynamics.   
2D planes are recorded with increasing delay times.  In the absence of exchange, the 
spectrum looks identical to that of a 15N/1H HSQC, with the peak for state A at 15NA/1HA and the 
peak for state B at 15NB/1HB (Fig. 6A,B).  When proper care is taken to eliminate other forms of 
relaxation (i.e. due to cross-correlation between 1H-15N dipole and 15N CSA), magnetization 
decays monoexponentially according to T1 during the mixing time.  If the system is in exchange, 
then there is the possibility that the amide will convert from state A to state B (or vice versa) 
before the magnetization is transferred from the amide nitrogen to its attached proton (i.e. during 
the mixing time).  The probability that this event will take place prior to the magnetization 
transfer is related to the delay time and the rate of exchange.  If this exchange occurs, then a peak 
for this amide will appear at 15NA/1HB (or 15NB/1HA in the alternative case).  Thus, auto-peaks 
(15NA/1HA, 15NB/1HB) will decay and cross-peaks (15NA/1HB, 15NB/1HA) will grow in as the delay 
time increases (Fig. 6A,B).   
A TROSY-selected ZZ-exchange experiment by Li and Palmer extends the application of 
ZZ-exchange experiments to large systems (Fig. 6C)43.  In this version of the experiment, the 
slowly relaxing narrow TROSY component of the 15N magnetization, SZIβ (where S is 15N and I 
is 1H), is selected for in both the mixing and frequency encoding periods of the pulse sequence.  
During the mixing period, the selected spin state, SZIβ, is longitudinal magnetization as before, 
and evolves as: 
15
!!" !!!!!!!!!! = −!∗! − !!" !!"!!" −!∗! − !!" !!!!!!!!!!  
where the intrinsic relaxation for each state is given by !∗ = !! − !!.  Here, !! is the average of 
the 15N and two-spin order relaxation rates, and !! is the longitudinal 15N-1H dipole/15N 
chemical shift anisotropy cross-correlated relaxation rate.  The pulse sequence is designed to 
ensure that, in the absence of exchange, the decay of the selected SZIβ magnetization is 
essentially monoexponential.  Thus, in the presence of exchange, the full solutions to the time-
dependent change in autopeak intensity (IAA and IBB) and crosspeak intensity (IAB and IBA) from 
their initial intensities (!!! and !!!) are given by: 
!!! ! = !!! !∗! + !!" !!!!! − !!!!!!! − !! + !!!!!!! − !!!!!!!!! − !!  
!!! ! = !!! !∗! + !!" !!!!! − !!!!!!! − !! + !!!!!!! − !!!!!!!!! − !!  
!!" ! = !!! !!"!!!!! − !!"!!!!!!! − !!  
!!" ! = !!! !!"!!!!! − !!"!!!!!!! − !!  
where 
!! = !∗! + !∗! + !!" + !!"2 + 12 !∗! − !∗! + !!" − !!" ! + 4!!"!!" 
!! = !∗! + !∗! + !!" + !!"2 − 12 !∗! − !∗! + !!" − !!" ! + 4!!"!!" 
This allows the quantification of two-state exchange in a large system, such as a membrane 
protein in a membrane-mimetic environment. 
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Scope of Thesis 
 In the chapters that follow, I will detail the bulk of the work that I have performed during 
my graduate studies, in conjunction with some supporting studies carried out by colleagues in the 
lab.  I will start by describing a modification to the EmrE reconstitution procedure that made my 
thesis work feasible, and then continue on to describe my biochemical and biophysical 
investigations into the mechanism of multidrug resistance in EmrE.  We first directly observed 
the conformational interconversion between inward- and outward-facing states of EmrE bound to 
the commonly studied ligand TPP+, characterized the interconverting states, and carried out our 
own definitive topological studies.  We then proceeded to explore the broad ligand specificity of 
EmrE by expanding the ligand profile used in our studies and connecting binding, transport, and 
conformational interconversion.  Together, these findings on the EmrE model system provide 
insight into multidrug efflux. 
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Figure 1.  Secondary active transport is is divided into symport (A) and antiport (B).  The 
cartoon diagrams here depict protons (black circles when bound) as the ion driving transport of 
substrate (red hexagon) by the transporter (green) across the membrane bilayer (salmon and 
black).  Note the forbidden transitions in each model.
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Figure 2.  Canonical multidrug recognition in transcription factors and transporters.  A.  The 
MDR regulator QacR binds proflavin (left) and ethidium (center) in different subsites and can 
even bind the two simultaneously (right).  Figure from Schumacher, et al., 2004.  B.  The MDR 
transporter AcrB binds minocycline (left) and doxorubicin (right) in separate but overlapping 
subsites.  Part of the protein was removed for clear visualization.  Figure from Murakami, et al., 
2006 (ref. 9).  The proteins are depicted as ribbons, with key residues represented as sticks.
A
B
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Figure 3.  Secondary structure diagram of EmrE.  Helix boundaries are based on the crystal 
structure of TPP+-bound EmrE.  The amino acid color guideline is as follows: hydrophobic in 
green, acidic and cysteine in red, polar in magenta, serine and threonine in cyan, basic in blue, 
and glycine and proline in orange.  Figure made using RbDe: Konvicka, et al. Protien Engineer-
ing (2000) 13: 395-6.
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Figure 4.  Structures of EmrE. A.  A 7.5 Å resolution cryoEM electron density map of TPP+- 
bound EmrE, with density contoured at 59.7 and viewed down the normal to the membrane 
bilayer (left).  Image from EMDataBank (EMD-1087).  A view rotated by 180° (right) shows the 
cryoEM density contoured at 1.2σ in mesh overlayed with the X-ray crystal structure (ribbon 
representation) shown in (C).  Figure from Chen, et al. 2007 (ref. 19).  B.  Fleishman’s model of 
TM helices, based on cryoEM data from (A).  The TPP+ is not explicitly shown.  Image made in 
PyMOL using PDB 2I68.  C.  The TPP+-bound X-ray crystal structure at 3.8 Å resolution 
(PyMOL, PDB 3B5D).  D. The drug-free X-ray crystal structure at 4.5 Å resolution (PyMOL, 
PDB 3B61).  Corresponding monomers are colored identically in (B) and (C).  (B)-(D) are 
viewed within the bilayer plane.
180º
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Figure 5.  Protein dynamics via solution 
NMR.  A.  A simplified energy diagram 
illustrates that dynamics occur on differ-
ent timescales.  A protein undergoing a 
large domain motion will exchange 
between multiple states (states A and B).  
However, each state is an ensemble of 
closely related substates.  These substates 
are separated by smaller energy barriers.  
Movement between states A and B occurs 
on the µs-ms timescale.  These states are 
separated in energy by ∆GAB, but move-
ment between the two states is met by the 
energetic barriers ΔG‡
A→B
 and ΔG‡
A→B
.  
Figure inspired by Henzler-Wildman and 
Kern, 2007 (ref. 40).  B.  Slow, global 
motions occur in different regimes on the 
NMR timescale, depending on the 
relationship between the exchange rate 
(kex) and the chemical shift difference 
between the two states (∆ν).  This 
relationship determines whether a sepa-
rate peak is observed for each state or a 
population-weighted average.  Figure 
from Kleckner and Foster, 2011 (ref. 42).
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Figure 6.  ZZ-exchange spectroscopy.  A.  A cartoon description of a ZZ-exchange experiment 
illustrates that chemical shift evolves on the amide nitrogen, followed by a delay, and then the 
magnetization is transferred to proton, where the chemical shift is recorded.  If the system is in 
slow exchange, the amide converts from state A to state B and vice versa during the delay time, 
with a probability proportional to the exchange rate.  B.  The resulting 2D spectrum shows only 
autopeaks when T = 0.  Cross peaks build in when T > 0.  Figures (A-B) inspired by Mittermaeir 
and Kay, 2009.  C.  Diagram of TROSY-selected ZZ-exchange pulse sequence.  The pulse 
representations are as follows: open bars are 90° pulses; filled bars are 180° pulses; short, open 
bars are rectangular, water-selective 90° pulses; and the striped bar is a 3-9-19 pulse.  The time 
delays are given by ∆ = 2.7 ms, ∆’ = 1.35 ms, and T is the variable mixing time.  Unless labeled 
otherwise, all pulses have a phase of x.  The phase cycle (for Bruker) is: Φ1 = Φ3 = 4(x, -x, -y, y); 
Φ2 = 2 (135°, 315°, 45°, 225°), 2 (315°, 135°, 225°, 45°); Φ4 = 4 (x, -x, y, -y); Φ5 = 2 (y, y, y, y, 
-y, -y, -y, -y); Φ6 = 2 (-y, -y, -y, -y, y, y, y, y); Φ7 = 4(-x, x, -y, y); Φ8 = 2 (x, x, x, x, -x, -x, -x, -x); 
Φrec = (x, -x, y, -y, x, -x, -y, y, -x, x, -y, y, -x, x, y, -y).  Phase Φ4 is incremented using States-TPPI 
to achieve quadrature detection in the indirect dimension.  The z gradients (PFG) have sine 
profiles with the parameters: G1 = 7.5 G/cm for 1.5 ms; G2 = G4 = 10 G/cm for 0.5 ms; G3 = 10 
G/cm for 1.5 ms; and G5 = 22.5 G/cm for 1.0 ms.  Figure from Li and Palmer, 2009 (ref. 43).
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Chapter II.  Reconstitution of integral membrane proteins into isotropic 
bicelles with improved sample stability and expanded lipid composition 
profile. 
 
 Optimization of the sample preparation for EmrE was key in making the bulk of my 
thesis work possible because solution NMR and other biophysical studies of EmrE require the 
production of stable, reproducible samples.  The purification of EmrE in the detergents dodecyl 
maltoside and decyl maltoside (DM) was well established1,2.  However, EmrE had not been 
previously studied in isotropic bicelles.  The two main methods for reconstitution of membrane 
proteins into isotropic bicelles are i) through organic solvents and ii) via detergent exchange into 
DHPC and subsequent addition of long-chain lipid.  As EmrE is monomeric and unfolded in 
organic solvent, we avoided method (i)3,4.  We initially reconstituted EmrE into isotropic bicelles 
via detergent exchange.  We tried exchanging EmrE from DM into DHPC when EmrE with an 
N-terminal 6× histidine tag was bound to Ni-NTA affinity resin.  However, we generally had a 
low recovery of EmrE using this method.  EmrE in DHPC appears to be unstable on Ni-NTA 
resin.  We also tried exchanging EmrE from DM into DHPC using a gel filtration column 
(S200).  However, as shown below, in contrast to predicted detergent removal using the critical 
micellar concentration and column volume, this method results in destabilizing residual detergent 
in the final sample.   
Samples prepared using these two detergent exchange methods displayed peak shifts 
between sample preparations, which is not acceptable in NMR studies.  In addition, they had 
variable sample stability, with samples showing precipitation after a few days at the elevated 
temperatures required for solution NMR experiments.  Our modified protocol involved 
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reconstituting EmrE into liposomes first and then adding short-chain lipid to break up the 
vesicles to form isotropic bicelles.  This method ensured complete detergent removal, and led to 
reproducible samples with long-term stability. 
 
Experiments were designed by E. Morrison and K. Henzler-Wildman and performed by 
E. Morrison. 
 
 
Supplementary Figure 1.  Cartoon depiction of the cross-section of EmrE reconstituted into 
isotropic bicelles (Graphical Abstract figure from5, PDB 3B5D). 
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Reconstitution of integral membrane proteins into membrane mimetic environments suitable for biophysical
and structural studies has long been a challenge. Isotropic bicelles promise the best of both worlds—keeping a
membrane protein surrounded by a small patch of bilayer-forming lipids while remaining small enough to
tumble isotropically and yield good solution NMR spectra. However, traditional methods for the
reconstitution of membrane proteins into isotropic bicelles expose the proteins to potentially destabilizing
environments. Reconstituting the protein into liposomes and then adding short-chain lipid to this mixture
produces bicelle samples while minimizing protein exposure to unfavorable environments. The result is
higher yield of protein reconstituted into bicelles and improved long-term stability, homogeneity, and
sample-to-sample reproducibility. This suggests better preservation of protein structure during the
reconstitution procedure and leads to decreased cost per sample, production of fewer samples, and reduction
of the NMR time needed to collect a high quality spectrum. Furthermore, this approach enabled
reconstitution of protein into isotropic bicelles with a wider range of lipid compositions. These results are
demonstrated with the small multidrug resistance transporter EmrE, a protein known to be highly sensitive
to its environment.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Structural and biophysical studies of membrane proteins have
traditionally lagged behind those of soluble proteins. One of the
major challenges of working with membrane proteins is finding a
membrane mimetic environment that is conducive to biophysical
studies while still maintaining native structure and function [1].
Techniques such as solution NMR have fast-tumbling requirements
that are not fulfilled by conventional lipid vesicles. Detergent
micelles, isotropic bicelles, and nanodiscs are some of the media
available for the solubilization of integral membrane proteins
(IMPs). The high curvature and altered lateral pressure of detergent
micelles make them a less than ideal membrane mimetic [1–4].
Detergents must be extensively screened to find a suitable match
that preserves native structure and function, and gentler detergents
such as alkylglycosides, which may better preserve function, are
often not conducive to multidimensional NMR studies [5].
Both isotropic bicelles and nanodiscs provide bilayer environ-
ments, and each media has its own merits. Nanodiscs are stable par-
ticles that can be separated by physical means such as gel filtration
chromatography, unlike isotropic bicelles in which the detergent is
in constant equilibrium between monomer and bicelle. This same
property of isotropic bicelles allows them to reconstitute at any size
by varying the long- to short-chain lipid ratio, whereas nanodiscs
can only make discretely sized particles. A new membrane scaffold
protein must be expressed and purified for each nanodisc size, and
they must be carefully tested to determine the proper ratio of
scaffold-to-lipid for each preparation [6]. In addition, NMR spectra
of IMPs reconstituted into nanodiscs tend to be broadened [1,2,7].
Use of isotropic bicelles has been limited by their stability and
spectral qualities [1,2]. Traditional methods for making bicelle
samples require harsh conditions that may not preserve proper
protein structure and function. Improved bicelle stability would
allow for more widespread use. Previous attempts at increasing
bicelle stability and sample lifetime have included using ether-
linked lipids and/or adding up to 10% of long- and short-chain lipids
with charged headgroups such as PS and PE-DTPA [4,8,9]. However,
recent studies have indicated that non-native ether-linked lipids
alter the structure and dynamics of antimicrobial peptides [10],
making this a less desirable substitution.
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Another challenge with isotropic bicelles is the relatively limited
lipid compositions currently in use. More varied lipid compositions
have been explored with magnetically aligned large bicelles for
solid-state NMR [1]. An expanded lipid composition profile would
allow for more physiologically relevant isotropic bicelles, similar to
nanodiscs, which can be formed with a range of lipids and lipid
extracts [2,6].
Here, we present an improved reconstitution of integral mem-
brane proteins into small isotropic bicelles that allows reconstitution
into bicelles with a much wider range of lipid compositions. This pro-
tocol is easily adaptable to any IMP of interest, with no requirement
for organic solvent or specific detergents. It also ensures complete
detergent removal, eliminating potential instabilities and inhomoge-
neities caused by residual detergent and providing an optimal sample
for biophysical studies. We have recently demonstrated the utility of
these bicelles for solution NMR dynamics measurements of EmrE
[11]. These cutting edge NMR measurements would not have been
possible without the improved sample stability and homogeneity
provided by this method.
2. Materials and methods
2.1. EmrE expression and purification
EmrE was expressed in a pET15b plasmid with an N-terminal
6xHis tag (Geoffrey Chang, Scripps Research Institute) and expressed
and purified as previously described [11]. Briefly, isotopically labeled
EmrE was grown in 15N- or 2H/15N-labeled M9 minimal media. To
purify EmrE, cells were lysed by sonication. The membranes were
solubilized in 40 mM DM (Affymetrix Anatrace), purified using
Ni-NTA resin (Novagen), and cleaved with thrombin (Sigma-Aldrich).
Final purification was performed by gel filtration chromatography on
a Superdex 200 column (GE Healthcare) equilibrated with 10 mM
DM. The purified EmrE was then reconstituted into isotropic bicelles
in deoxygenated buffers.
2.2. Sample preparation
2.2.1. Reconstitution into isotropic bicelles by detergent exchange
Purified EmrE was concentrated to 0.5 mL and DM reduced to less
than 30 mM, assuming monomeric detergent passed through the
filter while micelles were concentrated along with the protein. The
resulting sample was run over a Superdex 200 column equilibrated
with 25 mM DHPC (Avanti Polar Lipids). EmrE in DHPC was concen-
trated to 250 μL and long-chain lipid added to a final ratio of 3:1
short- to long-chain lipid (at least 75 mM long-chain lipid and 130-
fold excess of long-chain lipid:EmrE). Four freeze–thaw cycles were
carried out to ensure homogeneous bicelles.
2.2.2. Reconstitution into isotropic bicelles via liposomes
Long-chain lipid (DLPC, DMPC, DPPC, POPC, DOPC, POPE, POPG,
and Escherichia coli polar lipid extract, Avanti Polar Lipids) was
hydrated in buffer above the phase transition temperature for 1–2
hours at 20 mg/mL and then sonicated in a high-power bath sonicator
(Laboratory Supplies Company, Inc, Hicksville, NY). The lipid vesicles
were then incubated with 0.51% octylglucoside (Affymetrix Anatrace)
for 15–30 minutes. Purified EmrE in DMwas added at a molar ratio of
1:130, EmrE:long-chain lipid. After incubation for an additional
30–60 minutes, Amberlite (Supelco) was added to remove the deter-
gent. Three aliquots of 30 mg Amberlite per mg detergent were added
with incubation at room temperature for 1–2 hours, overnight, and
another 1–2 hours. The proteoliposomes were collected via ultracen-
trifugation (50,000×g, 1 hour, 20 °C) and resuspended in DHPC
buffer at a molar ratio of 3:1 short- to long-chain lipid, assuming a
90% recovery of long-chain lipid. The final lipid ratio in the bicelles
was confirmed by 1H-NMR using the lipid terminal methyl peaks.
The final buffer conditions for all NMR samples were 20 mM potassi-
um phosphate, 30 mM sodium cacodylate, 20 mMNaCl, 0.05% sodium
azide, 2 mM TCEP, pH 7, with 2 mM TPP+ and EmrE concentrations in
the range of 0.5–1.1 mM.
2.3. Transport assay
H+-driven uptake of the substrate dequalinium2+ was monitored
using fluorescence spectroscopy, following the fluorescence signal of
the substrate. EmrE was reconstituted into E. coli polar lipid extract
as described above with a lipid:EmrE dimer ratio of 640:1. The buffer
was 190 mM NH4Cl, 15 mM Tris pH 7 as in ref. [12]. The sample was
extruded through a 200 nm filter to create homogeneous vesicles.
The proteoliposomes were diluted ten-fold into either the same buff-
er (no H+ gradient) or a buffer of 140 mM KCl, 10 mM Tricine, 5 mM
MgCl2, 10 mM Tris pH 8 (H+ gradient). The final protein concentra-
tion was 1 μM. Transport was initiated upon the addition of concen-
trated dequalinium2+ to the bulk solution. The experiments were
carried out in a Varian Cary Eclipse fluorescence spectrometer, at an
excitation wavelength of 350 nm and emission wavelength of
460 nm.
2.4. Dynamic light scattering
DLS experiments were carried out on a DynaPro (model 99-E-50,
Protein solutions) with the Dynamics V6 software. The instrument
was calibrated with an albumin standard (Thermo Scientific) at
varying temperatures and concentrations. The NMR samples were
diluted four-fold to decrease secondary scattering effects, while still
maintaining sufficient lipid concentration to keep the same effective
q-value, or ratio of long- to short-chain lipids in the bicelle [13].
Data were collected at 10 °C and 25 °C, for five acquisitions of 5
minutes each.
2.5. Thin layer chromatography
TLC was carried out using Whatman K6 silica gel 60A plates and a
65:24:4 chloroform:methanol:water solvent system. Isotropic bicelle
samples were diluted 10-fold in 2:1 chloroform:methanol for
spotting onto the plates. After running the plates, they were dried
and developed in an iodine vapor chamber overnight.
2.6. Refractive index measurements
A Reichert-Jung Abbe Mark II digital refractometer with
water-bath temperature control was used to measure the refractive
indices of isotropic bicelles at the pertinent concentrations and
temperatures.
2.7. Viscosity measurements
A calibrated Cannon-Ubbelohde semi-micro viscometer, size 50,
was used to determine the viscosity of isotropic bicelles. Both refrac-
tive index and viscosity were measured under the same conditions
(lipid concentrations and temperatures) as the diffusion measure-
ments and used to calculate the hydrodynamic radius.
2.8. NMR spectroscopy
All experiments were carried out on a 700 MHz Varian Inova
spectrometer at 45 °C. Lipid ratios were confirmed by integrating
the terminal methyl resonances of the short- and long-chain lipids
in a 1H spectrum. Standard (1H, 15N)-TROSY HSQC spectra with
gradient coherence selection were acquired with 120 and 24 scans
per increment, respectively, for non-2H and 2H samples. (1H, 15N)-
TRACT [14] was used to measure rotational correlation times. The
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hydrodynamic radius (rh) is related to the rotational correlation time
(τc) by
τc ¼
4πηr3h
3kT
: ð1Þ
Data were processed and analyzed using NMRPipe [15] and
NMRView [16]. IgorPro (Wavemetrics) was used to fit the diffusion
data.
3. Results and discussion
3.1. Reconstitution of an integral membrane protein into isotropic
bicelles via liposomes improves bicelle stability and spectral quality
Integral membrane proteins (IMPs) are traditionally reconstituted
into isotropic bicelles [3] by two methods: i) direct reconstitution
from organic solvent or lyophilized powder; or ii) exchange into
DHPC micelles followed by addition of long-chain lipid. Highly stable
IMPs can be reconstituted through any method. However, multi-pass
α-helical IMPs are generally more sensitive to their environment and
handling during purification [17–19]. Organic solvents and lyophili-
zation must be avoided with these proteins, and many are not stable
in DHPC micelles. We reconstitute EmrE into vesicles of long-chain
lipid and then add DHPC to form bicelles (method iii). This protocol
is similar to a strategy used previously to reconstitute the GPCR
CXCR1 into large bicelles [20] for solid-state NMR.
EmrE, a 4-transmembrane helix homodimer, is highly sensitive
to detergent and lipid environment [18,21] and serves as a
representative system. EmrE is monomeric [22] and unfolded [23] in
organic solvent. However, it is a “functional” dimer in the detergent
dodecyl maltoside [24,25] based on ligand-binding, which provides
the best proxy for transporter function in a solubilized state. Thus
we eliminated organic solvent reconstitution protocols and focused
on methods with the potential to preserve EmrE structure and
function.
Initially, we reconstituted EmrE into isotropic bicelles via deter-
gent exchange (method ii) (Fig. 1A, B), but there are several disad-
vantages to this method. Running long gel filtration columns above
the critical micellar concentration of DHPC becomes prohibitively
expensive, and EmrE has diminished stability upon exchange into
DHPC micelles. In addition, residual DM remains in the samples
(Fig. 2). The yield, spectral quality, and stability of the samples were
variable, with protein precipitating in 2–14 days at 45 °C. In addition,
minor chemical shift changes were sometimes observed between in-
dependently prepared samples. Due to the conformational dynamics
of EmrE, NMR spectra are exquisitely sensitive to changes in the
bicelle environment, making sample reproducibility essential.
Reconstitution via liposomes (method iii) has two advantages.
First, it ensures complete detergent removal before the addition of
the short-chain lipid to break up the vesicles (Fig. 1A). This protocol
creates isotropic bicelles of well-defined composition and removes
the requirement for exchange into DHPC, thus making it suitable for
proteins not stable in this particular detergent-like lipid. Second, re-
constitution into a liposome allows transport assays to be performed,
ensuring that EmrE is fully functional immediately before the final
step of bicelle formation. We measured proton-driven uptake of
substrate by EmrE reconstituted into E. coli polar lipid liposomes
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Fig. 1. Overlay of (1H, 15N)-TROSY HSQC spectra of TPP+-bound EmrE in isotropic bicelles reconstituted by different methods. A) 15N-EmrE in DMPC/DHPC bicelles is better resolved
and has better signal/noise when reconstituted through liposomes (red) than when reconstituted through detergent exchange (black). B) The spectral quality of 15N-EmrE in
DMPC/DHPC bicelles degrades with time for EmrE reconstituted via detergent. After nearly 2 weeks at 45 °C, the spectrum (black) has less signal than the initial spectrum
(red). C) The spectrum of 2H/15N/13C-EmrE reconstituted into DLPC/DHPC bicelles via liposomes (red) is virtually unchanged after more than 6 months (black). D) 2H/15N-EmrE
can be stably reconstituted into isotropic bicelles made with different chain lengths (DLPC, blue; DMPC, red; DPPC, black), all capped by DHPC. The minor peak shifts indicate
only small changes in EmrE structure with change in bicelle thickness. All spectra were collected at 45 °C, in 20 mM KPi, 20 mM NaCl, 30 mM sodium cacodylate, pH 7.
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using Amberlite for detergent removal (Fig. 3). These assays use the
naturally fluorescent substrate dequalinium, which shows a
concentration-dependent increase in fluorescence at 460 nm. No up-
take is observed in the absence of a pH gradient. When a pH gradient
is introduced, the fluorescence change indicates dequalinium uptake
and concentration inside the liposomes, confirming that purification
and reconstitution into liposomes yields functional EmrE. Formation
of bicelles from the liposomes requires only the addition of DHPC
and several freeze–thaw cycles. A spectrum of TPP+-bound EmrE in
E. coli polar lipid bicelles (Fig. 4D), the lipid composition used for
the transport assays, indicates that the overall structure of EmrE is
the same in a variety of lipid environments. It is not possible to mea-
sure transport in the final bicelle, but substrate binding affinity and
stoichiometry[11] indicate that EmrE is still properly folded and
“functional” in bicelles.
2D TROSY spectra of 15N-EmrE reconstituted into DMPC/DHPC
isotropic bicelles by either method show that the liposome method
produces significantly better spectra (Fig. 1A). These spectra have
improved signal to noise for the same protein concentration and
sharper lines, consistent with a more homogeneous sample. In addi-
tion, spectra from independently prepared samples overlay exactly,
a requirement for specific-labeling-based assignment protocols.
Elevated temperatures are commonly used in NMR to improve
linewidth. To test stability under these conditions, the samples were
incubated in a water bath at 45 °C for nearly 2 weeks and then a sec-
ond spectrum was acquired to assess spectral changes. No significant
changes were observed for EmrE reconstituted via liposomes and
there was no precipitate. For EmrE reconstituted via detergent
exchange, precipitate was observed and the spectral quality declined
(Fig. 1B).
The long-term stability of the isotropic bicelles reconstituted via
liposomes is demonstrated in Fig. 1C. After 6 months of storage at
room temperature and weeks of NMR experiments at elevated
temperatures, a sample of 2H/15N/13C-EmrE in DLPC/DHPC bicelles
is unchanged. Contrary to previous reports [4,8], these samples are
stable for months without requiring expensive ether-linked lipids or
special lipid compositions.
We also experimented with the long-chain lipid composition of
the bicelles. A series of samples made using different acyl chain
lengths reveal only small local peak shifts (Fig. 1D). EmrE is an
E. coli protein, so we reconstituted EmrE into liposomes made with
E. coli polar extract. These varied in yield and spectral quality, likely
due to variability between batches of lipid extract. For a more defined
environment, we used two compositions designed to mimic E. coli
lipids. EmrE reconstituted well into isotropic bicelle preparations
using long-chain mixtures of i) 70% POPC, 20% POPE, 10% POPG, or
ii) 70% POPE, 20% POPG, 10% POPC. Overall, there are minimal
peak shifts of EmrE with changes in long-chain lipid composition,
but the peak-widths vary significantly (Fig. 4). This suggests that
A B
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Fig. 2. Thin layer chromatography to qualitatively assess lipid composition and hydrolysis of isotropic bicelle samples used for NMR spectroscopy. The standards include lipids as
well as the corresponding breakdown products—lysolipid and fatty acid. A) From left to right: 1) DPPC; 2) 16:0 lyso PC; 3) DMPC; 4) DLPC; 5) 12:0 lyso PC; 6) lauric acid; 7) DHPC;
8) 6:0 lyso PC; 9) hexanoic acid; 10) DLPC/DHPC q=0.33 bicelles; 11) DMPC/DHPC q=0.33 bicelles; 12) initial sample of 15N-EmrE in DMPC/DHPC isotropic bicelles reconstituted
through liposomes and 13) after 12 days at 45 °C; 14) initial sample of 15N-EmrE in DMPC/DHPC isotropic bicelles reconstituted through detergent exchange and 15) after 12 days
at 45 °C; and 16) 2H/15N/13C-EmrE after roughly 7 months. B) From left to right, repeat of lanes 10–16; 17) EmrE in 10 mM DM after S200 column during sample purification; and
18) 100 mM DM. Iodine vapor does not appear to be sufficient to visualize hexanoic acid.
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Fig. 3. EmrE is functional when reconstituted into liposomes: H+-driven uptake of the
substrate dequalinium2+ by EmrE reconstituted into E. coli polar liposomes, as
observed by monitoring dequalinium2+ fluorescence. Kinetics timecourses were
acquired with excitation at 350 nm and emission at 460 nm. At time zero, proteolipo-
somes at pH 7 are diluted into a buffer of pH 7 (no proton gradient) or pH 8 (proton
gradient). After roughly 30 sec, substrate is added. Assay was carried out with 1 μM
EmrE and 5 μM (red, bottom), 10 μM (blue, middle), and 20 μM (green, top) dequali-
nium2+ and in the presence (solid line) or absence (dashed line) of a H+ gradient.
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we are observing changes in dynamic rate rather than structure.
These samples demonstrate the potential for reconstitution of
IMPs into isotropic bicelles with a variety of lipid compositions
that better mimic native membranes for use in biophysical studies
[26,27].
3.2. Analysis of lipid hydrolysis in isotropic bicelles
We used TLC to assess lipid hydrolysis and residual detergent
(Fig. 2). The samples consist primarily of the bicelle lipids. Additional
minor lysolipid and fatty acid components indicate some lipid
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Fig. 4. EmrE was successfully reconstituted with a wide range of long-chain lipid compositions varying in saturation and head-group. (1H, 15N)-TROSY HSQC spectra of TPP+-bound
EmrE reconstituted into isotropic bicelles with the following long-chain lipid compositions: A) DPPC, B) POPC, C) DOPC, D) E. coli polar lipid extract, E) 70% POPE, 20% POPG, 10%
POPC, and F) 70% POPC, 20% POPE, 10% POPG. The DPPC spectrum was collected on 2H/15N-EmrE, while all others were collected on 1H/15N-EmrE. Spectra were collected under the
same conditions as above.
Table 1
Table of hydrodynamic radii of isotropic bicelles determined via DLS and rotational diffusion NMR.
Sample Hydrodynamic radius (nm)
Water Parametersa Bicelle Parametersb
DLS, 10 °C DLS, 25 °C DLS, 10 °C DLS, 25 °C NMR, 45 °C c
Reconstitution via liposomes, 15N EmrE in DMPC/DHPC bicelles 3.5±0.8 3.0±0.4 2.0±0.3 2.4±0.3 3.2±0.3
Reconsitution via detergent exchange, 15N EmrE in DMPC/DHPC bicelles 3.2±0.8 3.0±0.8 1.9±0.4 2.4±0.6 2.9±0.3
Reconstitution via liposomes, 2H/15N/13C EmrE in DLPC/DHPC bicelles 3.6±0.8 3.3±0.5 2.2±0.5 2.6±0.4 2.7±0.3
a RH values determined from DLS, using the viscosity and refractive index of water.
b RH values determined from DLS, using the viscosity and refractive index of the isotropic bicelle solution at the given temperature (see Materials and methods).
c Calculated from rotational correlation time using Eq. (1).
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hydrolysis; however, they are still only minor components after
6-months. If hydrolysis is a serious problem, a bicelle with ether-
linked lipids, such as DMPC/DIOHPC, can be utilized [9]. However, it
is preferable to use ester-linked lipids, as using the non-native
ether-lipids may alter the structure and dynamics of peptides in the
membrane [10]. An additional component, DM, is visible in the NMR
sample reconstituted via detergent exchange (Fig. 2), indicating that
the detergent was not fully removed. Precipitation of the NMR sam-
ples appears to correlate with small amounts of residual detergent.
3.3. Diffusion of EmrE reconstituted into isotropic bicelles
Disagreement exists in the literature regarding the morphology of
isotropic bicelles at small q-values—are they true discs (primarily
separated long- and short-chain domains) or mixed micelles? Based
on the small apparent hydrodynamic radii (RH) determined via DLS,
small q-value (≤0.5) mixtures of long- and short-chain lipids have
been differentially diagnosed as mixed micelles [28] or discs[13]. It
is difficult to determine shape from DLS data [13] alone and difficult
to interpret RH quantitatively. Electron microscopy [13] and AFM
[9], have been used to visually assess the morphology of these
mixtures. Discoidal structures were observed with both methods,
with larger discs and a few wormlike micelles also being observed
via AFM under more physiological conditions. Small angle neutron
scattering data also supports a disk-like model [29].
NMR spectroscopy has additionally been used to assess bicelle
morphology. 31P chemical shifts are different for DMPC and DHPC
headgroups, indicating different environments on average and thus
supporting significant separation of the lipids into distinct regions
[9,13]. Long- and short-chain lipids are differentially affected by para-
magnetic shift reagents, supporting separate regions for the two clas-
ses of lipids [29]. Translational diffusion measurements also indicate a
distinct separation [30]. Thus, the preponderance of data supports
significant domain separation of the long- and short-chain lipids, cre-
ating a bilayer-like environment around the protein. Even if lipid sep-
aration in the bicelles is incomplete, as is likely the case, this provides
a much more native-like environment than a detergent micelle. This
is further supported by proper ligand-binding affinity for small multi-
drug resistance transporters [3,4] and other IMPs [1,2] in bicelles.
The hydrodynamic radii of our isotropic bicelles (q=0.33) were
determined using DLS and NMR rotational diffusion data. Table 1
compares the hydrodynamic radii for EmrE samples reconstituted
through detergent exchange and via liposomes. There is no significant
change in hydrodynamic radius with reconstitution method, and the
radii are significantly smaller than those of nanodiscs [6]. Thus, spec-
tral differences between the two bicelle reconstitution methods are
not due to differences in overall particle size. Hydrodynamic radii in
Table 1 were calculated from the DLS data using both water and
isotropic bicelle solution viscosity and refractive index. These param-
eters have a significant effect on the hydrodynamic radius calculated
from DLS. Previous reports in the literature use values for water in
these calculations. However, as the bicelles are not at infinite dilution,
we also included hydrodynamic radii calculated using the solution
parameters measured directly on our bicelle solutions. Using the solu-
tion parameters for water, our data match that of bicelles shown to
have a discoidal morphology [13]. Additionally, (i) EmrE is unstable
in pure DHPC but very stable in bicelles and (ii) the NMR spectra
change significantly with long chain lipid composition (Fig. 4),
despite the fact that DHPC is the major component in our bicelles
(3:1 DHPC:long-chain lipid). This argues against the mixed micelle
model.
4. Conclusions
Conventional methods for reconstitution of integral membrane
proteins into isotropic bicelles require exposure of the protein to
organic solvent or DHPC micelles. These intermediate environments
can be destabilizing to sensitive IMPs. We have found that by first
reconstituting EmrE into liposomes and then breaking up the proteo-
liposomes with DHPC, we can achieve samples of higher spectral
quality and greater long-term stability. This method is broadly
applicable since the IMP may be reconstituted into liposomes using
any method suitable for the protein of interest. Addition of DHPC to
form isotropic bicelles from liposomes makes this protocol easy to
use and optimize relative to nanodiscs.
The environment-sensitive small multidrug resistance transporter
EmrE has been successfully reconstituted into isotropic bicelles of a
range of compositions using this protocol. Reconstituting EmrE via
liposomes has allowed us to assign the majority of backbone residues
and quantitatively measure slow timescale dynamics [11]. The
increased sample stability and homogeneity provided by this
reconstitution method was critical for the success of these novel
NMR experiments on an active transporter. Furthermore, the
(1H, 15N)-TROSY HSQC spectra in different lipid environments
presented here suggest that EmrE dynamics are significantly affected
by lipid composition. Experiments are in progress to further
investigate the effect of lipid environment on EmrE structure,
dynamics, and function.
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Chapter III.  Direct observation of conformational exchange in an 
asymmetric, antiparallel EmrE homodimer. 
 
This chapter is based on the published paper: EA Morrison*, GT DeKoster*, S Dutta, R 
Vafabakhsh, MW Clarkson, A Bahl, D Kern, T Ha, and KA Henzler-Wildman. “Antiparallel 
EmrE exports drugs by exchanging between asymmetric structures.” Nature. (2012) 481: 45-501. 
 
The key step in the single-site alternating-access model of antiport is the interconversion 
between the inward- and outward-facing states, as this is the step that actually moves substrate 
across the membrane barrier (Fig. 1).  According to this model, either two protons or one drug 
molecule can bind EmrE at a given time.  Thus, saturating EmrE with substrate should push 
EmrE into two-state exchange.  Does ligand binding actually push EmrE into two-state 
exchange, as predicted by single-site alternating-access model?  Our objective was to test this 
hypothesis and directly observe movement between the inward- and outward-facing states. Using 
solution-state NMR, we were able to quantify the kinetics and thermodynamics of global 
conformational exchange in the substrate-bound transporter, the key step for transport across the 
membrane. 
Within the single-site alternating-access framework for transport, there are several 
topological possibilities for the mechanism of exchange in a homodimeric protein (Fig. 2).  First, 
the homodimer could function as a parallel, symmetric dimer.  In this case, the dimer exchanges 
between AA and BB conformations such that the two monomers within each conformation are 
identical.  Each conformation has two-fold rotational symmetry around an axis parallel to the 
bilayer normal.  Secondly, the homodimer could function as an antiparallel dimer.  The 
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antiparallel homodimer could interconvert between two completely different conformations in 
which the monomers have different structures in the two conformations.  This is effectively an 
AB-to-CD exchange, with the first monomer exchanging between an A and C structure and the 
second monomer exchanging between a B and D structure.  This case lacks any symmetry 
relations.  However, the antiparallel homodimer could instead function with exchange symmetry.  
In this case the antiparallel homodimer effectively interconverts with itself in an AB-to-BA 
exchange.  This imparts a pseudo two-fold axis of symmetry around an axis parallel to the plane 
of the membrane bilayer.  Thirdly, the homodimer could exchange between antiparallel (AB) and 
parallel (CC) conformations, which would be highly unlikely considering that it would require 
one of the monomers to flip its orientation within the membrane.  A combination of solution 
NMR, fluorescence, and cross-linking experiments allowed us to determine the exchange 
mechanism for TPP+-bound EmrE. 
 
EmrE is functional in isotropic bicelles. 
Prior to our studies, EmrE had been studied in dodecylmaltoside (DDM) detergent 
micelles and liposomes of varying lipid composition2-8.  As elaborated in Chapter 2, the native 
lipid environment combined with the fast tumbling properties of the solubilized isotropic bicelle 
system make it an attractive system for biophysical studies of EmrE. As transport function 
cannot be assessed in a solubilized system, we measured transport before solubilizing 
proteoliposomes to form isotropic bicelles (Chapter 2)1,9 and then used binding as a proxy for 
function in the final bicellar environment.  We measured binding of TPP+, a commonly studied 
substrate, to EmrE reconstituted into DMPC/DHPC isotropic bicelles using isothermal titration 
calorimetry (ITC).  Isotropic bicelles are a dynamic system, meaning that the DHPC is in 
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equilibrium between bicelle and monomer.  Thus, diluting EmrE in bicelles with titrant would 
alter this equilibrium and create aberrant heats.  To address this issue the ligand was solubilized 
in a matched bicelle solution.  A flat reference titration of TPP+-bicelle solution into bicelles also 
indicated that we were not observing the binding or redistribution of TPP+ in lipid.   
For a direct comparison with the literature to show that our purification method produces 
functional EmrE, we first carried out the titrations with EmrE and TPP+ in equivalent DDM 
solutions at 4, 25, and 45°C (Fig. 3, Table 1).  EmrE is accepted to be a properly folded and 
functional dimer in DDM2-8,10.  All ITC experiments were performed at pH 7.  Since protons are 
competitive substrates of EmrE, drug binding is linked to pH.  The observed binding constant for 
TPP+ is tighter at higher pH values and weaker at lower pH values.  Thus, care must be taken 
when comparing to binding constants in the literature.  The titrations at 4°C produced curves 
with few points in the transition region, indicating that the binding was too tight to be accurately 
measured under the conditions required to produce measurable heats.  Published affinities in 
DDM are roughly 50 nM from [3H]TPP+-binding assays at pH 7 and 4°C8,11 and 19 ± 2 nM from 
ITC at pH 7.5 and an unreported temperature12, which is consistent with our results.  Agreement 
between our titrations in DDM (120 ± 12 nM) and isotropic bicelles (170 ± 70 nM) at 45°C (Fig. 
3C,D, Table 1) indicates that our reconstitution method produces functional EmrE in isotropic 
bicelles.  Some difference between detergent and bicelle environments is expected, especially 
since published dissociation constants for TPP+ binding to EmrE reconstituted into liposomes 
with varying ratios of DOPC, DOPE, and DOPG at pH 7.5 and an unreported temperature vary 
between 19 and 370 nM12.  In addition, our binding stoichiometries are all close to 0.5 for EmrE 
reconstituted in both DDM and bicelles (Table 1), which is consistent with an EmrE dimer 
binding a single TPP+ molecule.  Thus, our measured values for TPP+ binding to EmrE 
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reconstituted into DMPC/DHPC isotropic bicelles at pH 7 are consistent with a fully functional, 
dimeric protein. 
 Additional support for a properly folded and functional EmrE is provided by 15N/1H 
TROSY HSQC spectra of TPP+-bound EmrE reconstituted into both DDM micelles and isotropic 
bicelles (Fig. 4).  The spectra are well dispersed, indicating a folded protein.  In fact, the 
chemical shift dispersion is better than expected for an alpha helical membrane protein, which is 
likely due to the abundance of aromatic residues in the active site.  An overlay of these spectra 
(Fig. 4, DDM spectrum from K. Henzler-Wildman) shows that EmrE has the same overall 
structure in both environments.  Peaks shift between the two spectra, consistent with a change in 
environment, but overall, both spectra have the same chemical shift dispersion, peak pattern, and 
peak doubling.  A comparison of the two spectra also supports the notion that DDM is not 
optimal for NMR due to longer acquisition times and lower signal-to-noise13. 
 
EmrE interconverts between two conformations when bound to TPP+. 
 The 15N/1H TROSY HSQC spectrum of TPP+-bound EmrE in isotropic bicelles (or 
detergent micelles) reveals a global peak doubling (Fig. 4).  While EmrE has 105 non-proline 
residues, there are roughly 210 resolved peaks in its spectrum.  This overall peak doubling can be 
accounted for by an asymmetric dimer or exchange between two states.  Structural data from 
cryoEM and X-ray crystallography indicate that the EmrE dimer is asymmetric14-16, meaning that 
two monomers within the dimer have different structures and thus would have unique chemical 
shifts.  However, slow two-state exchange on the NMR timescale could also account for this 
global peak doubling.  The AA-to-BB exchange between two parallel dimers would have two 
sets of peaks, one from the identical monomers in the AA conformation and the second from the 
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identical monomers in the BB conformation (Fig. 2).  Only one of the antiparallel exchange 
mechanisms previously discussed is consistent with a complete peak doubling.  The more 
general AB-to-CD exchange would result in four complete sets of peaks, one from each of the 
different monomeric states (A, B, C, and D; Fig. 2).  However, the unique case of antiparallel 
exchange with exchange symmetry, or an AB-to-BA exchange, reduces this to only two sets of 
peaks.  This distinct exchange mechanism combines an asymmetric dimer with exchange on the 
NMR timescale.  Similar to antiparallel exchange with no symmetry, the antiparallel-to-parallel, 
or AB-to-CC, exchange would result in more peaks than were observed in the amide HSQC 
spectrum.  This mechanism would result in three sets of peaks, two from the asymmetric, 
antiparallel dimer, and one from the symmetric, parallel dimer (Fig. 2). 
 Thus, the models that are consistent with 210 peaks for a 105 non-proline amino acid 
protein are an asymmetric dimer that does not undergo slow exchange on the NMR timescale, a 
symmetric, parallel dimer undergoing exchange, or an asymmetric, antiparallel dimer undergoing 
exchange with exchange symmetry.  How can these three possibilities be distinguished?  As 
discussed in Chapter 1, solution NMR is ideal for measuring protein dynamics on different 
timescales.  Global domain motions that are slow on the NMR timescale (i.e. !!" ≪ ∆!, see 
Chapter 1) can be detected using ZZ-exchange spectroscopy17.  A modified version of the 
TROSY-selected ZZ-exchange experiment by Li and Palmer18 revealed the formation of cross 
peaks (Fig. 5).  As described in Chapter 1, the only way to observe cross peaks in a ZZ-
exchange experiment is if there is a slow exchange process on the NMR timescale.  At the 
concentrations of protein and ligand in the NMR tube, EmrE is fully saturated with ligand, and 
ligand association/dissociation will not be observed.  Thus, the global peak doubling is a result of 
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a two-state conformational exchange process, presumably exchange between the two low-energy 
conformations of TPP+-bound EmrE.   
The ZZ-exchange experiment also identifies exchange partners.  The cross-peaks 
complete boxes that connect the two states (A and B) of a single residue, as shown in Figure 5.  
The populations of the two states can be determined by integrating the two sets of peaks in a 
fully relaxed 15N/1H TROSY HSQC spectrum.  A histogram made from the relative volumes of 
the minor participant from each exchange partner with two well-resolved peaks is centered at 
about 0.5 (Fig. 6), indicating equal populations in the two states.  To get 50/50 populations with 
a symmetric dimer, AA and BB would need to be distinct conformations that happen to have 
equivalent free energies.  However, the antiparallel model with a pseudo two-fold axis of 
symmetry requires equal populations for the two exchanging states.   
As described in more detail in Chapter 1, the auto-peaks decay and cross-peaks grow in 
as the delay time increases.  The rates of these processes are governed by the forward (open-in to 
open-out) and reverse (open-out to open-in) rates of conformational exchange, which are 
equivalent because the populations of the two states of EmrE are equal.  Thus, there is only a 
single exchange rate (k) to fit.  There is additional decay due to the intrinsic relaxation (R*) of the 
magnetization during the delay time.  The overall change in magnetization in the two states A 
and B in the ZZ-exchange experiment as a function of time (t) is described by: 
!!" !! = −!∗! − ! !! −!∗! − ! !! . (1) 
The full solution to this system of differential equations describes the time-dependence of the 
intensities of the auto-peaks (IAA and IBB) and cross-peaks (IAB and IBA): !!! ! = !!! ! + !∗! !!!!!!!!!!!!!! + !!!!!!!!!!!!!!!!!!  (2) 
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!!! ! = !!! ! + !∗! !!!! − !!!!!! − !! + !!!!!! − !!!!!!!! − !!  
!!" ! = !!!! !!!! − !!!!!! − !!  
!!" ! = !!!! !!!! − !!!!!! − !!  
where 
!! = − !∗! + !∗!2 − ! + 12 !∗! − !∗! ! + 4!! 
!! = − !∗! + !∗!2 − ! − 12 !∗! − !∗! ! + 4!! 
and IA0 and IB0 are the initial intensities (at t = 0) of the peaks belonging to states A and B, 
respectively.  In practice, peak heights rather than peak volumes were used because the large 
EmrE-isotropic bicelle system has fast relaxation.  The resulting low signal-to-noise does not 
allow for accurate integration of volumes.  Peak heights were extracted for the auto- and cross-
peaks corresponding to the 13 residues with the best signal-to-noise.  A total of eight planes with 
increasing delay times were collected, and the data were fit to the full solution (eq. 2) with the 
residue-specific parameters IA0, IB0, R*A, and R*B and the global parameter k (Fig. 7).  This fit 
provided a value of 4.9 ± 0.5 s-1 for the rate of conformational interconversion.   
The correlation matrix of all of the parameters in the full fit (Fig. 8A, B) indicates that 
the global parameter k is not correlated with any of the residue-specific parameters.  However, 
for each residue, there is a strong correlation between !!! and !∗! and between !!! and !∗!.  This 
is not surprising, since peak intensity is dependent on intrinsic relaxation.  As expected, the state 
with the slower relaxation has a higher peak intensity (Fig. 8C). 
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The residue-specific intrinsic relaxation rates provide interesting insight.  It is common to 
make the simplifying assumption that the intrinsic relaxation rates of the two states are 
equivalent.  However, simple observation of the raw data (Fig. 7) shows that this is not the case 
for EmrE.  With equal populations in the two states, the intensities of the two auto- and cross-
peaks should overlay with each other.  For some residues this is the case, but for others it is clear 
that the intensities are not the same, which is emphasized by the residue-specific fit parameters 
(Fig. 9B).  In spin-state selective experiments (such as this TROSY-selected ZZ-exchange 
experiment), the intrinsic relaxation rate depends on relaxation properties of the amide proton 
and nitrogen.  As a result, differences in dynamics and proton exchange rates, which change with 
solvent accessibility, can also cause differences in the intrinsic relaxation rate of the two states.  
The variability between intrinsic relaxation rates is consistent with an alternating-access 
mechanism of exchange between inward- and outward-facing states, with each state open to only 
one side of the membrane at a time.  Some residues are in similar environments in both states, 
but others move from being in a protein-packed, more rigid state (closed face) to a looser, water-
accessible state (open face).  The residues with significant differences in intrinsic relaxation rate 
map to regions in loops and at the end of helices (Fig. 9A), consistent with this mechanism. 
In addition to the full fit, ZZ-exchange data can be analyzed using a simpler composite 
peak ratio analysis19.  This analysis has the benefit of eliminating the effects of differences in 
longitudinal relaxation between the two states during the mixing period, transfer efficiency, and 
transverse relaxation during detection19.  The composite peak ratio, Ξ ! , has a simple quadratic 
relationship with the delay time and is given by: Ξ ! = !!" ! !!" !!!! ! !!! ! !!!" ! !!" ! ≅ !!"#$!!"  !"  !"#$!!"#!!"#$!!"#  !"  !"#$!!"!! = !!!! (3) 
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Eleven residues have adequate signal-to-noise and all four peaks resolved, which is required for 
data analysis via this method.  A global fit to these 11 residues gives a conformational exchange 
rate of 4.7 ± 0.5 s-1 (Fig. 10).  The 160 ms plane was not used in this analysis due to the low 
signal-to-noise at long delay times.  For this same reason, several residues have abnormally low 
composite peak ratio values at 130 ms.  A jackknife error analysis indicated that no single 
residue skewed the fit and provided an estimate of the error.  
The agreement between the full fit and composite peak ratio analysis confirm that all 
residues are reporting on a global exchange process that occurs on a single timescale.  The 
residues used in the two analyses are distributed across the whole protein (Fig. 9A).  These 
analyses are also in agreement with tryptophan side chain dynamics (5 ± 2 s-1), which were 
measured using 15N-separated NOESY and ROESY spectra collected with variable mixing times 
(Fig. 11, K. Henzler-Wildman).  Considering the difference in conditions (environment and 
temperature), the rate of interconversion agrees with the rate of an unexplained slow phase 
observed in a series of stopped flow experiments carried out on DDM-solubilized EmrE at 
25°C11. 
 
TPP+-bound EmrE interconverts between two asymmetric, antiparallel conformations. 
 Additional experiments were required to determine EmrE topology and distinguish 
between the models of exchange between symmetric, parallel dimers and exchange between 
asymmetric, antiparallel dimers with exchange symmetry.  Bulk and single-molecule FRET and 
cross-linking experiments were used to determine the relative orientation of monomers within 
the EmrE dimer.  Single-cysteine mutants were used for these experiments.  The three native 
cysteines (C39, C41, and C95) were mutated to serine and single cysteines were added into 
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termini or loop positions (N2C, T56C, and Q81C).  These mutants have been used in published 
biochemical experiments and are known to be functional20-22.  Additionally, an overlay of 15N/1H 
TROSY HSQC spectra from WT and T56C on a cys-less background reveals the same peak 
pattern (Fig. 12, S. Dutta), supporting the same overall fold for the mutants.  
 Labeling for bulk fluorescence experiments was carried out on T56C-EmrE reconstituted 
into liposomes using the dye pair Alexa Fluor 488 (donor) and Alexa Fluor 568 (acceptor) (work 
done in conjunction with G. DeKoster).  This provided an environment to selectively label a 
single surface of the dimer.  To test for antiparallel dimers, EmrE was labeled with donor and 
acceptor fluorophores from opposite sides of the membrane (Fig. 13A).  First, one fluorophore 
was added to proteoliposomes.  This dye would only react with cysteines exposed to the exterior 
of the liposomes.  Then, the proteoliposomes were disrupted with detergent and the second 
fluorophore was added.  This dye would react with all remaining cysteines, i.e. the cysteines that 
were initially facing the liposomal interior.  The resulting sample was solubilized to form 
isotropic bicelles in order to isolate individual dimers and prevent interactions between 
fluorophores on different dimers.  In the case of an antiparallel dimer, this labeling scheme 
would result in one donor and one acceptor per dimer and thus FRET signal upon donor 
excitation.  In the case of a parallel dimer, this labeling scheme would instead result in either two 
donors or two acceptors per dimer, depending on the initial orientation of the dimer within the 
liposome, and thus no FRET signal upon donor excitation.  These samples showed FRET and 
thus support an antiparallel dimer (Fig. 13C, red line).   
On the other hand, to test for parallel dimers, T56C-EmrE in liposomes was 
simultaneously labeled with donor and acceptor fluorophores from one side of the membrane 
(Fig. 13B).  A mixture of the two dyes was added to the exterior of the liposomes, producing 
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dimers with only one monomer labeled with a dye molecule in the case of an antiparallel dimer.  
In the case of a parallel dimer, however, this method would produce a mixture of dimer 
populations with two donors, two acceptors, or one donor and one acceptor.  With this labeling 
scheme, the only scenario capable of producing FRET is the case of a parallel dimer with one 
donor and one acceptor dye.  These samples showed very little FRET upon donor excitation 
(Fig. 13C, blue line), which could also be due to dye leakage through the membrane or the 
formation of higher order oligomers.  As an additional control, samples were similarly made by 
labeling only from the exterior of the liposome, but only adding either donor or acceptor 
fluorophore.  After solubilizing into bicelles, donor-only and acceptor-only samples were mixed.  
This resulted in no FRET signal (Fig. 13C, black line), indicating that there was no monomer-
swapping between dimers and no direct excitation of acceptor.  
Single-molecule FRET (smFRET) studies were carried out to eliminate any concerns due 
to dye leakage during the labeling procedure and the formation of higher-order oligomers (work 
by S. Dutta and R. Vafabakhsh).  For these studies, the same single-cysteine mutants of EmrE 
(N2C, T56C, and Q81C) solubilized in DDM micelles were labeled simultaneously with donor 
and acceptor (Cy3/Cy5), resulting in statistical populations of EmrE labeled with two donors, 
two acceptors, or one donor and one acceptor, which is the population of interest.  The strength 
of a single-molecule technique for these topological studies is that it allows for characterization 
of each particle used in the analysis.  By selecting for particles that have single donor and single 
acceptor photobleaching events, there is complete certainty that any FRET signal is originating 
from a complex labeled with a single donor and a single acceptor fluorophore.  A single, narrow 
FRET distribution was obtained for each of three single-cysteine EmrE samples (Fig. 13D, Fig. 
14).  In the case of a symmetric, parallel dimer, two populations would be observed in the FRET 
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distribution: one with larger distance separation (lower FRET) corresponding to the open 
conformation, and a second with smaller distance separation (higher FRET) corresponding to the 
closed conformation where the loops and termini pack together to seal off access to the binding 
pocket (Fig. 2).  However, the case of an antiparallel dimer would result in only a single FRET 
distribution.  Although each fluorophore would be attached to a face of the protein that was 
alternating between open and closed conformations, the overall distance separation between the 
two fluorophores would remain the same (Fig. 2).  Thus, the observed single FRET distribution 
supports an antiparallel topology and corresponds to a FRET efficiency of 0.6-0.7, depending on 
the labeling location, which in turn corresponds to an inter-dye distance of 50-55 Å.  These 
distances are consistent with fluorophores that are on opposite sides of the membrane.  Based on 
the dimensions of the cryoEM structure, fluorophores that reacted on the same side of the 
membrane should be a no more than 35 Å apart, which would correspond to a FRET efficiency 
of greater than 0.9.  The three different single-cysteine mutants confirm that the same distances 
are observed independent of which site is labeled.   
The smFRET data alone does not distinguish between an antiparallel dimer with or 
without exchange symmetry.  However, the model of an asymmetric, antiparallel EmrE dimer 
with exchange symmetry is the only model that is in agreement with both the NMR and 
fluorescence data.  No conformational exchange was observed in the smFRET time traces, even 
though the rates measured by solution NMR would be on the observable timescale for the 
method, providing additional supporting idea of an AB-to-BA interconversion with the same 
distances in both the inward- and outward-facing states. 
Additional support for the model of an asymmetric, antiparallel dimer with exchange 
symmetry is provided by cross-linking experiments (work by S. Dutta).  Cross-linking 
46
experiments were carried out on S107C and S107C/K22R EmrE (both in a cys-less background) 
with the homobifunctional cross-linker o-PDM and the heterobifunctional cross-linker s-GMBS.  
O-PDM has a short, rigid connector and will only covalently cross-link two cysteines that are 
within close proximity.  Thus, o-PDM can only cross-link a parallel dimer, which has the two 
cysteines on the same side of the membrane (Fig. 15B, C).  On the other hand, s-GMBS 
covalently cross-links a sulfhydryl (cysteine) to a nearby primary amine (lysine sidechain or N-
terminus).  Under identical conditions, o-PDM partially cross-links S107C EmrE, but s-GMBS 
nearly completely cross-links this single-cysteine mutant (Fig. 15A, left).  The double mutant 
S107C/K22R eliminates cross-linking by s-GMBS (Fig. 15A, right), indicating that this 
compound cross-links S107C to K22 rather than the N-terminus, the only other primary amine in 
the protein.  Since K22 and S107C are on opposite sides of the membrane in the monomer, these 
two residues can only be cross-linked in an antiparallel homodimer (Fig. 15B, C).  Cross-linking 
by both o-PDM and s-GMBS is contradictory until considering the possibility of interactions 
between dimers.  Two dimers coming into close proximity can conceivably bring two C-termini 
close enough for cross-linking by o-PDM to occur.  In this situation, an increase in the relative 
concentration of EmrE within the membrane should result in an increase in cross-linking by the 
homobifunctional cross-linker.  As predicted, a 1:60 ratio of EmrE:lipid results in relatively 
equal populations of monomer and dimer, but a 1:20 ratio of EmrE:lipid results in nearly 
complete cross-linking by o-PDM (Fig. 15D).  As an additional control, cross-linking was 
performed in the presence of SDS, which monomerizes EmrE.  Neither cross-linker was 
effective in this case (Fig. 15A, left), showing that oligomerization is necessary for any cross-
linking to occur.   
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The NMR, fluorescence, and cross-linking experiments provide convincing evidence for 
the asymmetric, antiparallel model of EmrE with exchange symmetry, but are the two states we 
observe really the inward- and outward-facing states that the single-site alternating-access model 
predicts are the two low-energy states for TPP+-bound EmrE?  The regions that are closed in one 
conformation but open in the other (i.e. loops and ends of helices) will have different water 
accessibility.  Water accessibility can be assessed using a water-soluble paramagnetic probe, 
such as chelated gadolinium.  Paramagnetic ions increase the relaxation of nuclei in a distance-
dependent manner.  As a result, amides in close proximity to a paramagnetic ion will display 
line-broadening in a 15N/1H TROSY HSQC.  Collecting 15N/1H TROSY HSQC spectra at 
increasing concentrations of the probe provides a feel for the level of water accessibility of a 
given amide (work by G. DeKoster, Fig. 16A).  Some amides are equally protected from the 
gadolinium in both states and map to the transmembrane helices (Fig. 16B).  Others are equally 
broadened by the gadolinium in both states, and map to loop regions (Fig. 16B).  The most 
interesting residues are the ones that are differentially broadened, indicating a change in water 
accessibility between the two states.  These residues map to the pore region, loops, and ends of 
helices (Fig. 16B), and support the existence of two conformations that are each open to only one 
side of the membrane at a time, consistent with the alternating-access mechanism for transport. 
Mechanistic insight can be gained by looking at chemical shift differences between states 
A and B.  Chemical shift is sensitive to local structural changes, and thus chemical shift 
differences between the two states highlight local regions that change upon the AB-to-BA 
conformational interconversion, when the two monomers swap states.  As discussed previously, 
the ZZ-exchange experiment identifies exchange partners.  The 15N/1H TROSY HSQC can 
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essentially be separated into a spectral fingerprint for each state (Fig. 17), allowing for the 
calculation of chemical shift differences according to: ∆! = ∆!! ! + ∆!! 10 ! (4) 
where Δω is an average of the difference between states A and B of the amide proton (ΔωH) and 
amide nitrogen (ΔωN) chemical shifts, weighted by gyromagnetic ratio.  There is a large variation 
in chemical shift difference across the protein sequence (Fig. 18A), indicating that some regions 
have larger structural changes upon exchanging states.  Plotting these differences on the crystal 
structure of TPP+-bound EmrE shows that the largest changes localize to several regions (Fig. 
18B).  Since the crystal structure has a monomer in each state, rotating the monomer in state B 
by 180° and placing it onto the monomer in state A orients the two monomers in the same way 
and makes these changes easier to visualize.  By aligning TM1-TM3, it becomes clear that TM1-
TM3, the helices that form the binding pocket, have relatively small chemical shift changes and 
behave largely as a rigid unit that is simply reoriented upon interconversion.  The largest 
chemical shift changes in this region are located in the loops, the C-terminal end of TM1, and the 
C-terminal half of TM3.  The changes in the loops and C-terminal end of TM1 are consistent 
with the changes that must occur to alternatingly close-off and open-up each side of the 
membrane in the alternating-access mechanism.  The large changes in the C-terminal half of 
TM3 are consistent with the kink at the GVG motif in state A that straightens in state B.  The 
side of TM4 that faces the TM1-TM3 bundle also has some of the largest chemical shift changes 
due to the reorientation of TM4 with respect to the rest of the protein.  The regions that have the 
largest chemical shift changes coincide with regions that are important mechanistically for the 
conformational interconversion. 
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 We have directly observed the two-state exchange between inward- and outward-facing 
states of TPP+-bound EmrE.  Along with solution NMR, fluorescence and cross-linking 
experiments confirm the unique model where EmrE is both asymmetric and undergoes a 
conformational exchange.  Asymmetric, antiparallel EmrE has a pseudo 2-fold axis of symmetry, 
such that the inward- and outward-facing states are identical.  This model resolves the apparent 
clash between the asymmetric, antiparallel structural data and the functional symmetry of 
residues in the active site. 
 
Methods (modified from1): 	   EmrE expression and purification. EmrE was expressed using a pET15b plasmid 
provided by G. Chang15. This vector produces EmrE with an amino (N)-terminal 6×His tag that 
can be removed by cleavage with thrombin to leave only three extra N-terminal residues (GSH). 
The final protein sequence after cleavage is: GSH MNPYIYLGGA ILAEVIGTTL 
MKFSEGFTRL WPSVGTIICY CASFWLLAQT LAYIPTGIAY AIWSGVGIVL 
ISLLSWGFFG QRLDLPAIIG MMLICAGVLI INLLSRSTPH.  BL21(DE3) cells transformed 
with this vector were grown in M9 minimal media. EmrE was induced with 0.33 mM IPTG at an 
optical density (OD600) of 0.7–0.8 at 17 °C.  Cells were harvested after 14-20 hrs.  1H/15N-
labeled EmrE was produced in the same way substituting 1 g 15NH4Cl. 2H/15N-labelled EmrE 
was produced by growing cells in 2H/15N M9 (1 g 15NH4Cl, 2 g glucose, 12.8 g Na2HPO47H2O, 
3.0 g KH2PO4, 0.5 g NaCl, 2 mL 1 M MgSO4 in D2O, 100 mL 1 M CaCl2 in D2O, 100 mg 
ampicillin, one generic multivitamin, and 0.5 g 2H/15N Isogro (Sigma) per liter).  
 Cell pellets were re-suspended in lysis buffer (100 mM NaCl, 2.5 mM MgSO4, 20mM 
tris pH 7.5, 250 mM sucrose, 5 mM β-mercaptoethanol, 1mg/mL lysozyme, DNaseI, 1 mg/mL 
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pepstatin, 10 mM leupeptin and 100 mM PMSF) and lysed by sonication. The membrane 
fraction was separated by a high-speed spin (30,000 ×g for 1 hr), re-suspended in the same buffer 
and solubilized with 40 mM decylmaltoside (DM, Anatrace) at room temperature for 2 hrs. After 
a second high-speed spin, the supernatant was applied to Ni-NTA HisBind beads (Novagen) 
prewashed with buffer A (10 mM DM, 10 mM KCl, 90 mM NaCl, 20 mM tris, pH 7.8, 5 mM β-
mercaptoethanol) and allowed to bind for 15-30 min at room temperature. The beads were 
washed with 10 bed volumes of buffer A, followed by 10 bed volumes of buffer B (buffer A + 5 
mM imidazole). EmrE was eluted with five bed volumes of elution buffer (buffer A + 400 mM 
imidazole). The salt concentration was increased to 200-250 mM and thrombin was added to 
cleave the His-tag overnight at room temperature. Samples were then concentrated and 0.5ml 
aliquots and loaded onto a Superdex 200 column pre-equilibrated with NMR buffer (20 mM 
potassium phosphate, 20 mM NaCl, pH 7.0) with 10 mM DM. The protein eluted near 14-15 ml 
with a symmetric peak. Fractions containing EmrE were combined and reconstituted into 
bicelles. For samples in dodecylmaltoside (DDM, Anatrace), DDM was substituted for DM 
throughout the protocol and the FPLC were combined and concentrated to the desired final 
protein/detergent concentration.  
Preparation of isotropic bicelles. First, the amount of EmrE in the combined FPLC 
fractions was determined as described below. Long-chain lipid (DLPC (1,2-dilauroyl-sn-glycero-
3-phosphocholine) or DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine), Avanti Polar 
Lipids) was hydrated in NMR buffer at 20 mg/mL. A molar ratio of at least 200:1 lipid:EmrE 
dimer was used for all samples. The lipids were bath sonicated for 10 min and 0.51% octyl 
glucoside (Anatrace) was added. After 20 min, they were mixed with the FPLC fractions 
containing EmrE and incubated for 30 min. Three aliquots of 30 mg BioBeads (BioRad) per 
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milligram of total detergent were used to remove the detergent. After removal of the BioBeads, 
the vesicles were collected by ultracentrifugation at 50,000 ×g for 1 hr at 20 °C. The supernatant 
was removed and the pellet was re-suspended in NMR buffer containing DHPC (1,2-dihexanoyl-
sn-glycero-3-phosphocholine, Avanti Polar Lipids) to break the liposomes up into bicelles. The 
DHPC concentration was calculated to produce a 1:3 ratio of long-chain lipid:DHPC, assuming 
85-90% recovery of long-chain lipid. Four freeze–thaw cycles were used to produce uniform 
bicelles.  Samples were stored at -80°C until use. 
EmrE concentration determination. EmrE concentration was determined using 
absorbance at 280 nm. The extinction coefficient (38,370 M-1cm-1) was calibrated using amino 
acid analysis of three samples of EmrE each in DDM and DM, and was found to be the same for 
EmrE in bicelles. 
Isothermal Titration Calorimetry. ITC experiments were performed using a VP-ITC 
titration microcalorimeter (MicroCal) by titrating TPP+ (50–80 µM) into EmrE (9–13 µM) in 
isotropic bicelles (qeffective = 0.3323, DMPC/DHPC) or 5 mM analytical grade DDM. Both the 
TPP+ and EmrE solutions were in NMR buffer and had matching detergent or lipid 
concentrations. Matching bicelle stocks were produced by acquiring proton NMR spectra of all 
samples (empty bicelle blank, TPP+ stock, and EmrE stock), integrating the DMPC and DHPC 
terminal methyl peaks, and ensuring that the lipid ratio and peak volumes matched. Isotropic 
bicelle samples had a total lipid concentration of 30-50 mM and qeffective = 0.33. The TPP+ 
concentration in the final stock solution was determined spectrophotometrically (ε = 4,400 M-
1cm-1 at 269 nm and 3,750 M-1cm-1 at 276 nm). Heats of dilution were determined from reference 
titrations of the same TPP+ stock into empty micelles or bicelles. Data were fit to a model of the 
ligand TPP+ (X) binding to n independent and identical sites on the macromolecule EmrE (M) to 
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determine the association constant (K), enthalpy of binding (ΔH) and binding stoichiometry (n), 
using equation (5): !!!"! = !!∆! ∙!!!"! !"#!!!" (5) 
where x is the free ligand concentration, Mitot is the total macromolecule concentration, Qitot is 
total heat after the ith injection and Vo is the cell volume. The data were fit with a nonlinear least-
squares approach using the ITC Data Analysis in Origin software supplied with the calorimeter 
(OriginLab). 
Error was determined from standard deviation between replicate experiments. The K 
values from each replicate were averaged, and then the average value was converted to the 
dissociation constant, Kd.  
Bulk FRET sample preparation and measurement. All FRET and cross-linking 
experiments used single-cysteine mutants of EmrE: the three native cysteines were mutated to 
serine and a single cysteine was introduced at the desired location. T56C-EmrE was reduced 
with DTT and then reconstituted into DMPC liposomes with a molar ratio at least 300:1 
lipid:EmrE monomer. After ultracentrifugation to collect the liposomes, they were re-suspended 
in deoxygenated NMR buffer with 2 mM cysteine and extruded through 400 µm filters to 
produce unilamellar vesicles loaded with cysteine. The sample was passed over a G25 Sephadex 
column to remove free cysteine from the exterior of the liposomes. The tight-binding substrate 
TPP+ was maintained at saturating concentrations throughout the preparation to stabilize EmrE 
dimers and prevent monomer swapping. 
To test for antiparallel topology, the first dye-maleimide was added to the exterior of the 
liposomes at a 5-fold molar excess relative to EmrE monomer. The reaction was allowed to 
proceed for 30 min, and then quenched by addition of 20-fold excess of β-mercaptoethanol. Free 
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dye was removed by collecting the liposomes via ultracentrifugation, re-suspending the 
liposomes in fresh buffer, and repeating the ultracentrifugation. The second dye-maleimide was 
added along with octyl glucoside to disrupt the liposomes. The reaction was allowed to proceed 
for 1 hr and then quenched as before. Free dye and detergent were removed by passing the 
sample over a G25 Sephadex column. DHPC was then added to the liposome suspension to form 
bicelles. Alexa Fluor 488 was used as the donor and Alexa Fluor 568 as the acceptor for bulk 
FRET experiments. 
To test for parallel topology, samples were produced in a similar manner, but labeled 
with mixed donor and acceptor only from the exterior of the liposome. After the labeling 
reaction, remaining free dye was quenched and removed, and then DHPC was added to form 
bicelles. This should produce EmrE with only one face labeled by fluorescent dye, and any 
cysteine that faces the interior of the liposome should remain unlabeled. Two additional control 
samples were independently labeled with either donor only or acceptor only from the exterior of 
the liposome and then mixed. 
Fluorescence measurements were made using a PTI spectrofluorimeter (Photon 
Technology International) using FeliX fluorescence analysis software version 1.42b (Photon 
Technology International). Labeled T56C-EmrE samples were diluted into isotropic bicelles or 
5% SDS containing 2 mM TPP+. The donor, Alexa Fluor 488 was excited at a wavelength of 488 
nm and emission spectra were collected scanning from 500 to 750 nm. The acceptor, Alexa Fluor 
568, was excited at a wavelength of 568 nm and emission spectra were collected scanning from 
580 to 750 nm. 
Single-molecule FRET experiments. Three different single-cysteine mutants, N2C, 
Q81C and T56C, were labeled with Cy3-maleimide and Cy5-maleimide for single-molecule 
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FRET experiments. Labeling was performed in the same manner as bulk FRET samples or by 
labeling EmrE in detergent micelles using an equimolar mixture of donor and acceptor before 
reconstitution into isotropic bicelles as previously described. The final bicelles used for single-
molecule FRET experiments contained 0.1% biotinyl-DPPE for immobilizing the samples. 
Single-molecule experiments were performed on a wide-field total internal reflection 
fluorescence microscope set up24. Biotinylated bicelles containing Cy3 and Cy5 labeled EmrE 
were specifically immobilized on a polymer-coated quartz surface. Then free bicelles were 
flushed out of the chamber and molecules were imaged in the imaging buffer consisting of 3 mM 
Trolox and the oxygen scavenger system (0.8% dextrose, 0.1 mg/mL glucose oxidase, 0.02 
mg/mL catalase) in NMR buffer (2 mM TPP+, 20 mM NaCl, 20 mM potassium phosphate, pH 
7.0). A 532 green laser (Coherent) was used for Cy3 excitation and the sample was imaged by a 
charge-coupled-device camera (iXon DV 887-BI; Andor Technology). Homemade IDL and C++ 
programs were used to record and analyze the movies. FRET efficiency was calculated from !! !! + !! , where ID and IA are the donor (Cy3) and acceptor (Cy5) fluorescent intensities, 
respectively. 
For each sample, several minute-long movies were collected (imaging area 70 µm × 35 
µm) at 100 ms time resolution. Donor and acceptor intensity time traces were corrected for the 
background and smoothed using four-point adjacent-averaging. FRET efficiencies from 
molecules that showed single Cy3 and Cy5 photobleaching steps were chosen to build the 
histograms.  
Cross-linking of EmrE. o-PDM (N,N’-(o-phenylene)dimaleimide) and s-GMBS were 
used to cross-link S107C EmrE to test for parallel (o-PDM) or antiparallel (s-GMBS) topology. 
These experiments were performed with 90 µM EmrE, 20 mM potassium phosphate, 20 mM 
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sodium chloride, 1 mM TCEP, pH 7, and cross-linking for 20 min at 37°C followed by 
quenching with β-mercaptoethanol at 20-fold excess over the cross-linker concentration. Cross-
linking in detergent was performed in 10 mM DM; cross-linking in lipid was performed in 
DLPC liposomes at the specified protein:lipid ratio. Addition of SDS monomerizes EmrE and 
provides a control. S107/K22R serves as a control to determine whether the lysine side chain or 
N-terminal amine participates in the s-GMBS cross-linking reaction. 
NMR sample preparation and data acquisition. All NMR samples were 0.5 – 1.0 mM 
2H/15N-EmrE, and contained excess (2 mM) TPP+ to saturate the protein with substrate. The 
sample in DDM (Fig. 4A, green) had 118 mM DDM. All other NMR samples were in isotropic 
bicelles as described above, with at least 100:1 long-chain lipid:EmrE molar ratio, total lipid 
concentrations of 300-400 mM and q ≈ 0.33. The q-value was confirmed for each sample by 
integrating the DMPC (or DLPC) and DHPC methyl resonances. All NMR samples were 
prepared in 20 mM potassium phosphate, 20 mM NaCl buffer, pH 7.0, and contained 0.05% 
NaN3, 2 mM TCEP and 10% D2O. 
Two-dimensional TROSY spectra and the 15N-separated nuclear Overhauser 
enhancement spectroscopy (NOESY)–HSQC and rotating frame nuclear Overhauser 
spectroscopy (ROESY)–HSQC spectra were acquired on a 700 MHz Varian spectrometer 
equipped with a room-temperature probe using standard pulse sequences with gradient coherence 
selection. The TROSY-selected ZZ-exchange experiment18 was modified to include a lipid 
‘flipback’ pulse.  To accomplish this, a UBURP pulse was added immediately preceding the 
back-transfer (i.e. directly before the pulse labeled ϕ5 in Fig. 6C of Chapter 1).  This UBURP 
pulse was centered at 2.9 ppm, with a bandwidth of 2.6 ppm and power optimized for 
suppression of lipid signal.  These spectra were acquired on a 800 MHz Bruker spectrometer 
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equipped with a cryoprobe. ZZ- exchange spectra were acquired with mixing times of 20, 30, 40, 
50, 80, 100, 130, 160 ms with 128 scans per increment and 128 complex points in the indirect 
dimension.  
Eighty percent of the backbone resonances were assigned using a non-standard protocol 
that combined standard triple resonance experiments with amino-acid-specific labeling and ZZ-
exchange data.  3D TROSY-HNCA, TROSY-HNCO, and TROSY-HN(CO)CA spectra were 
collected to walk the backbone.  Low signal-to-noise caused by long experiments on a large, 
dynamic system in addition to the high degree of overlap in the central region of the spectra 
meant that there were many places where assignments were ambiguous and the walk along the 
backbone was broken.  Single-tryptophan mutants (W31Y, W45Y, and W76Y) were produced to 
assign those residues, and the active-site residue W63 was assigned via process of elimination.  
Specific amino acid labeling was performed to simplify the spectra.  Amino acid typing was 
carried out using samples made with specific 13C’/14N/1H amino acids (Phe, Tyr, Leu, Gly, Ile, 
Ala, and Val) added to a uniform 12C/15N/2H background25.  These samples produced 15N/1H 
TROSY HSQC spectra where the specifically labeled amino acid (i) dropped out.  In addition, 
only the i + 1 residue was observed in an HNCO plane.  The TROSY-selected ZZ-exchange 
experiment was used to assign exchange partners.  However, the central region is highly 
crowded.  Specific 15N amino acids (Ile and Leu) were added to a uniform 14N/2H background 
for simplified ZZ-exchange experiments.  Residue and state assignments were confirmed using a 
15N-separated 1H-1H NOESY. 
NMR data were processed and analyzed with NMRPipe26, NMRView27, Sparky28, and 
IgorPro (Wavemetrics). All EmrE structure figures were created in PyMOL using Protein Data 
Bank 3B5D with the backbone rebuilt to render the cartoons.  
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Table 1. Isothermal Titration Calorimetry Data: EmrE binding to TPP+ 
 
Sample Temperature 
(°C) 
KA (M-1) na Average KD (nM) Average n 
DDM micelles 4 2.03 x 107 
1.36 x 107 
0.52 
0.48 
60 ± 20  0.50 ± 0.05 
25 2.47 x 107 
1.81 x 107 
0.51 
0.52 
50 ± 10  0.52 ± 0.05 
45 8.60 x 106 
8.02 x 106 
0.52 
0.50 
 
120 ± 12  0.51 ± 0.05 
Isotropic 
bicellesb 
 
45 4.18 x 106 
1.04 x 107 
4.96 x 106 
6.51 x 106 
3.94x 106 
5.06 x 106 
0.44 
0.53 
0.41 
0.47 
0.44 
0.46 
170 ± 70  0.46 ± 0.05 
 
a Binding stoichiometry, ligand/protein.  
b qeff = 0.33 DMPC/DHPC bicelles. Replicates are from 3 independently prepared samples. 
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Figure 1.  Conformational interconversion in transport mechanism of EmrE.  A.  Cartoon of 
single-site alternating-access transport by EmrE.  In each step of the tranpsort cycle, EmrE is 
only open to one side of the membrane at a time.  EmrE can only alternate access of its binding 
site between the two sides of the membrane when substrate (either two protons or one drug 
molecule) is bound.  B.  Proposed interconversion between open-in and open-out conformations 
of antiparallel, asymmetric EmrE.  The two structures are related by a 180° rotation around an 
axis parallel to the membrane bilayer, going directly into the page.  The two monomers are 
colored differently (blue and green), and TPP+ is shown in magenta.  Figures from Morrison, et 
al. 2012 (ref. 1).
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Figure 2.  Possible models of conformational interconversion by a homodimeric transporter.  
Such a transporter can have a parallel or antiparallel topology with varying symmetry relation-
ships, as described in more detail in the text.  Qualitative data predictions are shown for each the 
four models depicted.  Within each model, unique monomeric states (with unique chemical 
shifts) are labeled with a different letter (A, B, C, or D) and color.  The coloring connects each 
monomeric state to a corresponding peak for a single amide in the predicted NMR spectra.  Peak 
size indicates relative populations of the different states.  Two peaks within a spectrum are only 
the same size if the model requires that the corresponding two states have equal populations.  
The expected smFRET results correspond to a dye pair attached at the positions of the red and 
green circles, which are at the same residue on all monomers.  Dashed green circles highlight 
outcomes that could be consistent with the experimental results, as described in more detail in 
the text.  Solid green circles indicate the only possibilities that are supported by all the experi-
mental data.  Figure from Morrison, et al. 2012 (ref. 1).
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Figure 3.  EmrE binds TPP+ comparably in DDM and isotropic bicelles.  Representative traces 
for ITC experiments performed in DDM at 4°C (A), 25°C (B), and 45°C (C) and in isotropic 
bicelles at 45°C (D).  All samples were made in 20 mM KPi, 20 mM NaCl, pH 7.0.  Fits for all 
ITC experiments are shown in Table 1.  Figures from Morrison, et al. 2012 (ref. 1).
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Figure 4.  EmrE has the same structure in DDM and isotropic bicelles.  15N/1H TROSY HSQC 
spectra of TPP+-bound 2H/15N EmrE solubilized in DDM micelles (A, green) or reconstituted 
into DMPC/DHPC (A and B, black) or DLPC/DHPC (B, red) isotropic bicelles.  Figures from 
Morrison, et al. 2012 (ref. 1).
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Figure 5.  TPP+-bound EmrE is in slow exchange.  Overlay of 15N/1H TROSY HSQC spectrum 
(black) and 100 ms mixing time TROSY-selected ZZ-exchange plane (red) of TPP+-bound 
2H/15N EmrE.  Blue boxes connect auto- and crosspeaks from amides of individual residues, 
some of which are labeled with their residue number.  Figure from Morrison, et al. 2012 (ref. 1).
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Figure 6.  Population histogram of TPP+-bound EmrE.  All fully-resolved peak pairs in a fully-
relaxed (6 s recycle delay) 15N/1H TROSY HSQC spectrum were integrated.  Populations were 
determined from the relative volumes of the two peaks in each pair.  The minor population from 
each pair was plotted in the histogram, which indicates that the populations in the two states are 
equal.  The average population of the minor state is 0.47 ± 0.3.  Figure from Morrison, et al. 
2012 (ref. 1).
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Figure 7.  Full fits to ZZ-exchange data.  Fits of peak intensity of auto- (data in filled circles, fits 
in solid lines) and cross- (data in open circles, fits in dashed lines) peaks as a function of mixing 
time in the TROSY-selected ZZ-exchange experiment.  Thirteen residues are plotted between 
four graphs for easier visualization.  Within each graph, auto- and crosspeaks for a single residue 
are plotted in the same color.  Error bars are estimated from the noise of each spectrum.  Data 
from the 13 residues were globally fit to an exchange rate of 4.9 ± 0.5 s-1.  Figures from Morri-
son, et al. 2012 (ref. 1).
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Figure 8.  Correlation between variables in the full fit to the ZZ-exchange data 
(eq. 2) .  A correlation matrix is plotted in (B) for the single global parameter (k) 
and four residue-specific parameters (IA
0, IB
0, R*A, R*B) for each of the 13 residues 
included in the global fit (see Fig. 7).  The numbering key is listed in (A).  No 
correlation is evident between k and any residue-specific parameter.  There is 
strong correlation between I0 and R* for each state.  Plotting I0 vs. R* (C), with 
each residue in a different color, shows that the state with faster relaxation has a 
lower initial intensity, as expected.  The one outlier has lower signal-to-noise 
than most of the other residues analyzed, and one of the cross peaks is not as 
well resolved.  Figures from Morrison, et al. 2012 (ref. 1).
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Figure 9.  Differential relaxation between states A and B.  A.  The residues used in the quantita-
tive analysis of the ZZ-exchange data are colored on the structure.  Residues shown in red have 
the same intrinsic relaxation rate in both states, while those colored yellow have different relax-
ation rates between the two states.  B.  The rates used in (A) are plotted here.  Figures from 
Morrison, et al. 2012 (ref. 1).
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Figure 10.  Global exchange process.  A global fit to the 11 best-resolved residues using the 
composite peak ratio analysis (Ξ, eq. 3) gives a conformational exchange rate of k = 4.7 ± 0.5 s-1, 
in agreement with the full fit (eq. 2, Fig. 7).  Each residue is plotted in a different color, with the 
global fit plotted as a solid line and dashed lines plotted for k = 4 s-1 and 6 s-1 for comparison.  
Low data points at 130 ms are due to the low signal-to-noise of peaks for some residues at this 
long mixing time.  Figure from Morrison, et al. 2012 (ref. 1).
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Figure 11.  Tryptophan side-chain dynamics.  The NOESY/ROESY analysis of tryptophan 
side-chain dynamics is in agreement with conformational exchange rate determined from ZZ-
exchange spectroscopy.  A.  Two planes from a 3D 15N-separated NOESY spectrum of TPP+-
bound EmrE in q = 0.33 DMPC/DHPC isotropic bicelles at 45°C, pH 7.  Dashed red lines 
connect the crosspeaks in the 1H NOESY dimension for two of the Trp side-chain amides (W45 
and W76).  The crosspeaks are nearly identical for each pair, as expected for exchange partners.  
B.  The 1H-1H plane from a 3D 15N-separated ROESY spectrum of the same sample showing the 
region highlighted by the blue square in (A).  Contours of opposite sign are colored red and 
black.  All the crosspeaks in this region have the same sign as the diagonal, indicating that these 
crosspeaks are due to exchange and not NOE/ROE.  C.  Diagonal- and crosspeak volumes were 
extracted from the NOESY spectra as a function of time.  The average of the diagonal peak 
volumes (black) and the average of the crosspeak volumes (colored) are plotted for each of the 
two resolved Trp.  Fitting to a simple equation assuming equal relaxation rates in both states 
yields the same conformational exchange rate, k = 5 s-1, as for the ZZ-exchange analysis.  Fig-
ures from Morrison, et al. 2012 (ref. 1); data from K. Henzler-Wildman.
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Figure 12.  Single-cysteine mutant of EmrE has the same overall fold.  An overlay of 15N/1H 
TROSY HSQC spectra of TPP+-bound 2H/15N-WT (black) and 1H/15N-T56C (red) EmrE in q = 
0.33 DLPC/DHPC isotropic bicelles at 45°C, pH 7.  Some small chemical shift differences are 
observed, as may be expected due to mutation of the three native cysteines to serine in addition 
to the T56C mutation.  The overall spectrum is quite similar, indicating a stable, properly folded 
structure for this mutant.  Figure from Morrison, et al. 2012 (ref. 1); data from S. Dutta.
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Figure 13.  Topological studies of EmrE.  T56C-EmrE in liposomes was labeled with fluores-
cent dyes according to two different schemes.  A.  Labeling with a single dye on each side of the 
membrane will produce FRET only if EmrE is antiparallel.  B.  Labeling with both donor and 
acceptor from the same side of the membrane will produce FRET only if EmrE is parallel.  C.  
Observation of both donor (Alexa Fluor 488) and acceptor (Alexa Fluor 568) fluorescence upon 
donor excitation in a sample labeled according to the scheme in (A) indicates FRET and an 
antiparallel topology (red line).  In contrast, only minimal FRET was observed in a sample 
labeled according to the scheme in (B) (blue line).  The control (black line) excludes monomers 
swapping between dimers and direct excitation of acceptor.  All fluorescence spectra are normal-
ized to total donor fluorescence in SDS, which monomerizes EmrE.  D.  For smFRET experi-
ments, N2C-, T56C-, or Q81C-EmrE was labeled with Cy3/Cy5 in micelles and then reconsti-
tuted into bicelles.  Particles containing one donor and one acceptor were selected based on 
photobleaching events (see Fig. 14).  A single, narrow FRET distribution is observed in each 
case, with a FRET efficiency consistent with an antiparallel topology.  Data from S. Dutta.  E.  
Positions of donor/acceptor labeling for fluorescence experiments: T56C (orange), Q81C (blue), 
or N2C (red; residue 4 or 6 is colored because the N-terminus is missing from the crystal struc-
ture).  Figure made in PyMOL with PDB 3B5D.  Figure from Morrison, et al. 2012 (ref. 1).
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Figure 14.  Sample smFRET time traces for single-cysteine labeled EmrE.  Donor fluorescence 
(green), acceptor fluorescence (red), and FRET (blue) for Cy3/Cy5-labeled N2C-EmrE (A), 
T46C-EmrE (B), and Q81C-EmrE (C).  Experiments were performed in DLPC/DHPC isotropic 
bicelles at pH 7, with saturating concentrations of TPP+ in the imaging buffer.  Traces are shown 
for molecules that had only two photobleaching events, one donor and one acceptor.  A large 
proportion of the single particles observed fall into this class.  Data of this type was binned into 
histograms based on FRET efficiency, as plotted in Fig. 13D.  Figures from Morrison, et al. 2012 
(ref. 1); data from S. Dutta.
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BFigure 15.  Cross-linking experiments support an antiparallel topology.  SDS-PAGE gels show 
the results of cross-linking experiments using two different bifunctional cross-linking reagents to 
cross-link EmrE in DDM micelles.  O-PDM, a homobifunctional cross-linker, will covalently 
link two cysteines.  S-GMBS, a heterobifunctional cross-linker, will covalently link a cysteine 
sulfhydryl to a primary amine.  A.  In S107C-EmrE, cross-linking occurs with partial efficiency 
with o-PDM and nearly 100% efficiency with s-GMBS.  SDS monomerizes EmrE and prevents 
cross-linking.  S-GMBS does not cross-link S107C/K22R-EmrE, demonstrating that K22 rather 
than the N-terminus cross-links with S107C.  Cartoons illustrate cross-linking locations for an 
antiparallel (B) and parallel (C) EmrE dimer.  Cross-linking of an antiparallel dimer by o-PDM 
can be explained by cross-linking between dimers.  In a parallel dimer, s-GMBS cannot cross-
link K22 to S107C.  D.  As expected for inter-dimer cross-linking, o-PDM cross-linking 
efficiency depends on the protein:lipid ratio.  At a ratio of 1:60, cross-linking is only about 50% 
efficient, but this increases to nearly complete cross-linking at a ratio of 1:20.  Two identical 
lanes were run for each sample.  Figure from Morrison, et al. 2012 (ref. 1); data from S. Dutta.
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Figure 16.  EmrE has asymmetric water accessibility.  A.  Overlay of 15N/1H TROSY HSQC 
spectra of TPP+-bound EmrE in the absence (black) and presence of 1 mM (blue) and 5 mM 
(red) of paramagnetic gadobenate dimeglumine.  Residues with differential PRE effects (green 
circles) or the same PRE effect (black circles) in the two states are highlighted.  B.  Residues 
with equal accessibility (dark blue) or protection (red) from water in both states are plotted on 
the structure.  Grey residues are not assigned in both states.  Residues with differential water 
accessibility (yellow) highlight the pore and loop regions, as expected for exchange between 
inward- and outward-facing conformations.  This is consistent with an antiparallel dimer open to 
only one side of the membrane at a time, as in the X-ray crystal structure.  Figure made using 
PyMOL, PDB 3B5D.  Figures from Morrison, et al. 2012 (ref. 1); data from G. DeKoster.
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Figure 17.  EmrE assignments.  15N/1H TROSY HSQC spectrum (black) of TPP+-bound 2H/15N 
EmrE.  Residues are labeled with assignments in state A (red) and state B (blue).  Due to a lack 
in connectivity, A vs. B is not known with certainty for residues 17, 31, 67, 98, and 108.
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Figure 18.  Changes in chemical shifts upon interconversion between inward- and outward-
facing states of EmrE.  Chemical shift differences between states A and B for all assigned 
residues were calculated according to eq. 4 (A) and plotted on the X-ray crystal structure of 
asymmetric, antiparallel EmrE (PDB 3B5D, B).  The monomer in state A was rotated 180° onto 
the monomer in state B, and TM1-TM3 were aligned in PyMOL.  This view highlights the 
structural differences between the two monomers and the corresponding chemical shift differ-
ences.  Figures from Morrison, et al. 2012 (ref. 1).
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Chapter IV.  Transported substrate determines exchange rate in the 
multidrug resistance transporter EmrE. 
 
 In the previous chapter, we demonstrated that we could directly monitor the 
conformational interconversion between the inward- and outward-facing states of EmrE bound to 
TPP+.  Using solution NMR we were able to gain valuable insight into this mechanism by 
characterizing the kinetics and thermodynamics of this exchange along with structural details.  
The next step was to apply these tools to address the question of broad substrate specificity.  As a 
member of the family of smallest transporters, EmrE must accommodate a wide range of ligands, 
spanning tetrahedral and planar geometries, a range of sizes, and +1 or +2 charge, into a single 
small binding pocket and undergo the same global motion to alternate access of its binding 
pocket between opposing faces of the membrane bilayer. 
 The manuscript that follows is published in The Journal of Biological Chemistry1 and 
presented here with additional figures.  It describes a series of isothermal titration calorimetry, 
in-cell efflux assays, and ZZ-exchange spectroscopy to assess differences in EmrE bound to a 
range of substrates.  The results of these experiments indicate that EmrE binds a series of five 
related monovalent and tetrahedral compounds with affinities varying over three orders of 
magnitude.  Amazingly, the rate of conformational exchange of EmrE bound to these five related 
compounds also varies to a similar extent.  The energetic implications of the binding 
thermodynamics and exchange kinetics are discussed in detail in the manuscript text, but one of 
the most remarkable findings is simply the sheer magnitude of these kinetic differences.  The 
conformational interconversion between the inward- and outward-facing states is a large-scale 
concerted motion, and it can be difficult to conceive that the timescale of this motion can be 
78
tuned to such a high degree.  A change in ligand structure as small as the addition of a single 
methyl group is able to affect these dynamics.   
In this manuscript, we start to explore the mechanism of this dynamic modulation using 
chemical shift analysis, however, further experiments will be required to understand the basis for 
the substrate-dependent effects.  A future direction for the lab will be to follow up on Tate’s low-
resolution cryo-EM studies that suggest a change in helix tilt between when bound to tetrahedral 
and planar ligands.  Using NMR to measure residual dipolar couplings, we will be able to test 
this and measure the precise tilt angle of each TM helix when EmrE is bound to different ligands.  
Additional distance restraints between ligand and residues of interest, gathered via paramagnetic 
NMR and EPR, will also provide additional data on the structural changes induced by the 
binding of different ligands. 
 
Experiments were designed by E. Morrison and K. Henzler-Wildman, performed by E. 
Morrison, and analyzed by E. Morrison and K. Henzler-Wildman. 
 
References: 
1. Morrison, E. A. & Henzler-Wildman, K. A. Transported Substrate Determines Exchange 
Rate in the Multidrug Resistance Transporter EmrE. Journal of Biological Chemistry 289, 6825–
6836 (2014). 
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Background:  EmrE transports a broad range of compounds. 
Results:  EmrE converts between open-in and open-out states with rates that vary over 3 orders 
of magnitude, depending on substrate.   
Conclusions:  Substrate affects both ground-state and transition-state energies for 
conformational exchange, emphasizing the coupling between substrate binding and transport. 
Significance:  Drug identity determines its own rate of transport by EmrE. 
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ABSTRACT 
EmrE, a small multidrug resistance transporter, serves as an ideal model to study 
coupling between multidrug recognition and protein function.  EmrE has a single small binding 
pocket that must accommodate the full range of diverse substrates recognized by this 
transporter.  We have studied a series of tetrahedral compounds, as well as several planar 
substrates, to examine multidrug recognition and transport by EmrE.  Here we show that even 
within this limited series, the rate of interconversion between the inward- and outward-facing 
states of EmrE varies over three orders of magnitude.  Thus, the identity of the bound substrate 
controls the rate of this critical step in the transport process. The binding affinity also varies over 
a similar range and is correlated with substrate hydrophobicity within the tetrahedral substrate 
series. Substrate identity influences both the ground-state and transition-state energies for the 
conformational exchange process, highlighting the coupling between substrate binding and 
transport required for alternating-access antiport.  
 
Multidrug transporters are an ideal system for investigating the proposed alternating-
access model since their diverse substrates provide a natural toolkit of small molecules to probe 
the molecular mechanism. At the molecular level, active transport of a substrate against its 
electrochemical gradient requires two distinct conformations of the transporter, one open to the 
inner side of the membrane and one open to the outer side of the membrane, and the ability to 
convert between these two states to move bound substrate across the membrane (1) (Fig. 1B). 
Within this alternating-access framework, stoichiometric antiport can be achieved with two 
simple conditions: (i) the counter-transported substrates compete for a single binding site such 
that the transporter cannot bind both substrates simultaneously, and (ii) the transporter is able to 
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interconvert between the inward- and outward-facing states only when a substrate is bound. 
Energetically, substrate binding must lower the barrier for conformational exchange between the 
inward- and outward-facing states. This tight coupling between substrate binding and 
conformational exchange is important for secondary active transporters that use a proton gradient 
to drive transport, so that the proton motive force needed for ATP synthesis is not dissipated 
unnecessarily. 
But how is substrate binding and conformational exchange coupled in the context of a 
small multidrug resistance transporter such as EmrE, which recognizes and transports many 
different substrates?  EmrE imports two protons across the inner membrane of E. coli for each 
polyaromatic cation substrate exported, conferring resistance to a broad range of drugs that meet 
this chemical description (2-4). The simple single-site alternating-access model of antiport 
described above is consistent with the biochemical data available for EmrE (5-8). Recent solid-
state NMR studies of tetraphenylphosphonium+ (TPP+) and methyltriphenylphosphonium+ 
(MeTPP+) binding to EmrE in liposomes have confirmed that TPP+ binds directly to the active 
site glutamate, E14, and both substrates compete for the same binding site as proposed (9). 
Polyaromatic cation substrates of EmrE vary in charge (i.e. +1 vs. +2), geometry (i.e. planar vs. 
tetrahedral), and overall size. Their binding affinities vary widely, reflecting this substrate 
diversity (2), yet binding of any of these substrates must trigger the same open-in to open-out 
conformational exchange process in order for transport to occur. Does this important 
interconversion between open-in and open-out states occur on the same timescale for different 
substrates? If not, are there substrate properties that determine conformational exchange rate and 
ultimately the ability of EmrE to confer resistance to a particular substrate? 
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The very small size of EmrE, which functions as a homodimer with only 110 residues per 
monomer, raises an additional question: How does such a small protein recognize and actively 
transport this diverse array of compounds? Multidrug resistance (MDR) proteins are unique in 
their ability to bind a wide range of ligands and different families of MDR proteins appear to 
have evolved distinct strategies to recognize diverse compounds. Large MDR transporters from 
several superfamilies and MDR gene regulators appear to bind different drugs with distinct 
subgroups of residues within a large, hydrophobic binding pocket, and some can even bind 
multiple substrates simultaneously (10-12).  As a member of the smallest family of MDR 
transporters, EmrE has a small binding pocket that must accommodate its entire wide range of 
substrates within a limited space.  Multidrug recognition in a single small binding pocket has 
already been established in one case, the MDR transcription factor BmrR (13).  In BmrR, the 
same set of active site residues interacts with its full array of ligands in a highly rigid binding 
pocket (13). This is in contrast to the canonical concept of multidrug recognition (11, 12), which 
postulates a key role for flexibility in accommodating diverse ligands in a single site.  However, 
the requirements for coupling substrate binding to function are fundamentally different in 
transcription factors and transporters.  Indeed, low-resolution cryo-EM data indicates that EmrE 
alters its structure when bound to planar or tetrahedral substrates (2). Thus, we expect flexibility 
is important in multidrug recognition by EmrE and that nature has successfully adopted different 
strategies for multi-substrate recognition in multidrug binding proteins of different sizes and 
functions. Here we experimentally test how multidrug recognition is achieved by EmrE and 
coupled to functional transport. 
We have previously directly monitored the dynamics of the conformational 
interconversion between the open-in and open-out states of EmrE bound to the well-studied 
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substrate TPP+ (14). Now we expand this work to test the hypothesis that the rate of 
conformational exchange between inward- and outward-facing states, the key step in moving 
substrate across the membrane, depends on the identity of the transported substrate.  By 
combining NMR dynamics techniques with binding and efflux assays, we directly observe 
structural details, thermodynamics, and kinetics to link multisubstrate binding with functional 
motions.  
 
EXPERIMENTAL PROCEDURES 
Expression, purification, and reconstitution of EmrE—EmrE was expressed, purified, 
and reconstituted as previously described (14, 15).  Isotopically labeled samples were extensively 
deuterated by growing in D2O M9 media supplemented with 1g/L 15NH4Cl, 0.5g/L 2H /15N 
isogro (Sigma-Isotec), and 2g/L 1H/12C D-glucose.  Purified EmrE was reconstituted into 1:3 
DLPC/DHPC or DMPC/DHPC (mol/mol) isotropic bicelles at a 1:100 molar ratio of 
protein:long-chain lipid in 20mM potassium phosphate (KPi), 20mM NaCl, pH 7. 
Partition coefficients—Partition coefficients were measured via the HPLC method (16).  
Reference and sample compounds were dissolved in 75% MeOH:25% buffer at roughly 
2mg/mL.  5µL samples were injected onto an analytical Waters Sunfire C18 reverse-phase 
column with isocratic flow of 70% MeOH:30% buffer at 1mL/min.  The dead time (t0) of the 
column was taken as the retention time of the highly polar thiourea.  A capacity factor, c, for 
each ligand was calculated from retention time (tR): ! = !! − !! !! .  A reference curve of 
log(c) vs. well-established experimental values of logP for phenol, p-cresol, 4-chlorophenol, 1-
naphthol, 4-phenylphenol, and naphthalene was fit to: !"#$ = ! + !×log  (!) (16).  The logP 
values for the ligands were then calculated from this standard curve. 
84
 The propidium2+ (PP2+) retention time increases with increasing methanol and decreasing 
sample concentration, most likely reflecting aggregation of the ligand.  The asymptotic value 
(logP = 4.3) of a dilution series was taken as the true logP, and error bars are larger for this 
ligand to reflect the greater uncertainty in logP.  Repeating the logP determination at 50% 
methanol does not significantly alter the outcome for any of the tetrahedral ligands or 
dequalinium2+ (DQ2+).  However, PP2+ does shift to logP = 2.5, as the asymptote of a dilution 
series. 
Extinction coefficient determination for ligands—Extinction coefficients were 
determined for TPP+-derivatives for accurate concentration determination.  Extinction 
coefficients for TPP+ determined in the same manner matched literature values (i.e. 3750 M-1cm-
1 at 275nm, 4400 M-1cm-1 at 268nm, and 3350 M-1cm-1 at 262nm), confirming the accuracy of 
this method.  Extinction coefficients were determined in H2O for MeTPP+ chloride (Sigma-
Aldrich), ethyltriphenylphosphonium+ (EtTPP+) chloride (Acros Organics), and 2-
methylbenzyltriphenylphosphonium+ (MBTPP+) bromide (Acros Organics).  Due to its low 
solubility, stocks of 2,5-diethoxyphenyltriphenylphosphonium+ (DPhTPP+) iodide (Aldrich 
Chemicals) were prepared in methanol, and dilutions were made into water for measurements.  
The molar extinction coefficients were determined from 5 to 6 independently weighed and 
prepared samples: a) MeTPP+: 2460, 2875, and 2150 M-1cm-1 at 274, 267, and 261 nm; b) 
EtTPP+: 2470, 2980, and 2260 M-1cm-1 at 274, 267, and 261 nm; c) DPhTPP+: 4480, 3040, 3390, 
and 2870 M-1cm-1 at 321, 275, 268, and 262 nm; and d) MBTPP+: 3720, 4270, and 3340 M-1cm-1 
at 276, 268, and 263 nm.  The extinction coefficients of the planar ligands are: 5680 M-1cm-1 at 
478nm for ethidium+ (Eth+) (17) and 5900 M-1cm-1 at 493nm for PP2+ (EMD Millipore).  The 
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absorbance of DQ2+ is 27,500 M-1cm-1 at 329nm in aqueous solutions (18) and 28,875 M-1cm-1 in 
decylmaltoside solution (determined by dilution of aqueous stocks). 
Isothermal titration calorimetry—All ITC experiments were performed with EmrE 
reconstituted into qeffective = 0.33 (19) DLPC/DHPC isotropic bicelles under NMR conditions 
(20mM KPi, 20mM NaCl, pH 7, 45°C).  Isotropic bicelle solutions were matched between 
protein and ligand samples, with at least a 100:1 DLPC:protein ratio, never going below 40mM 
total lipid to preserve bicelle morphology (19).  Triplicate titrations were carried out for each of 
the seven ligands.  Injections ranged from 1-2.5 µL, with stirring at 300-350 rpm.  Ligand 
concentrations were determined using extinction coefficients determined as described above.  
Titrations were performed for each ligand using an average of 900, 600, 40, 35, 30, 650, and 700 
µM EmrE and 5, 3, 0.2, 0.14, 0.13, 4, and 4 mM ligand for MeTPP+, EtTPP+, TPP+, DPhTPP+, 
MBTPP+, PP2+, and DQ2+ titrations, respectively.  Due to limitations on sample concentrations, 
the weakest (MeTPP+, PP2+, and DQ2+) and tightest (MBTPP+) binders have greater error in the 
determination of KD.   
ITC was performed on a TA Instruments Low Volume Nano calorimeter using ITCRun 
software and analyzed using ITCAnalysis software (TA Instruments, Lindon, UT).  Data were fit 
to a model of ligand binding to n independent and identical sites on EmrE, as in (14).  Blank 
titrations of ligand and bicelles into bicelles always yielded equivalent heats across the titration, 
but it is difficult to precisely match to each sample.  Therefore, the data were fit simultaneously 
to the binding model and a constant to represent the baseline of bicelle mixing. 
In-cell transport assay—In-cell Eth+ efflux assays based on work from the laboratories of 
Le Pecq and Schuldiner (20, 21) were carried out in BL21(DE3) and BL21(DE3) Gold strains of 
E. coli transformed with EmrE in pET15b or an empty pET15b control vector in M9 media 
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supplemented with 100 µg/mL ampicillin.  At an OD600 = 0.4, over-expression was induced with 
0.33 mM IPTG for 30 min.  40 µM CCCP and 2.5 µM ethidium bromide were added, followed 
by incubation at 37°C for an additional hour.  Individual 2 mL aliquots were spun down and 
resuspended immediately in 2 mL M9 media with or without 40 µM CCCP and 2.5 µM ligand 
(Eth+, MeTPP+, EtTPP+, TPP+, MBTPP+, or DPhTPP+).  Eth+ fluorescence was measured with 
excitation at 545 nm and emission at 610 nm.  Normalized fluorescence (FN) was plotted as !! ! = ! ! − !! !!. 
NMR spectroscopy and data analysis—Data were collected on 0.8-1.0 mM 2H/15N EmrE 
reconstituted into q = 0.33 DLPC/DHPC isotropic bicelles in 20 mM KPi (+30 mM cacodylate 
for PP2+ sample), 20 mM NaCl, pH 7, at 45°C.  Ligand was added to 10 mM, 5 mM, 16 mM, and 
2 mM for MeTPP+, EtTPP+, MBTPP+, and TPP+, respectively.  Due to the low solubility of 
DPhTPP+, PP2+, and DQ2+, these samples were incubated with excess ligand at 45°C to push the 
samples to saturation.  Most of the NMR data were collected on a 700MHz Varian Inova 
spectrometer with a room temperature probe.  Temperature was calibrated from ethylene glycol 
peak splitting.  The DQ2+ data was collected on the Rocky Mountain Regional 900 MHz Varian 
DD2 spectrometer with room temperature probe.  The data for EmrE in DMPC/DHPC isotropic 
bicelles bound to TPP+ was collected on the Varian 900 MHz spectrometer with cryo probe at 
NMRFAM.  1H/15N TROSY HSQCs were collected with 24 scans and 128 complex increments, 
with recycle delays of 2 s for standard spectra and 6 s for lineshape analysis.  The TROSY-
selected ZZ-exchange experiment (22) was modified and run as described previously (14).  
Spectra were collected with 144, 128, 176-256, 128, and 288 scans and 144, 128, 128, 128, and 
150 complex increments for EtTPP+, MBTPP+, DPhTPP+, PP2+, and DQ2+, respectively.  NMR 
spectra were processed with NMRPipe (23) and analyzed in NMRViewJ (24), Sparky (25), and 
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CcpNmr Analysis (26).  ZZ-exchange and lineshape data analysis was carried out in Igor Pro 
(Wavemetrics). 
Assignments were transferred from TPP+-bound EmrE (14) to EmrE bound to the other 
four TPP+-derivatives using data from the HSQC and ZZ-exchange spectra.  The ZZ-exchange 
data significantly reduces the ambiguity of transferred assignments. Only assignments that could 
be transferred with certainty were used in the analyses. 
To extract the conformational interconversion rate, kconf, the ZZ-exchange data for EmrE 
bound to each ligand were analyzed in the style of Miloushev, et al (27) as described previously 
for TPP+-bound EmrE (14). With equal populations in the inward- and outward-facing 
conformations of EmrE (14), the forward (kf) and reverse rates (kr) in this two-state exchange are 
equal and denoted by kconf = kf = kr.  The composite peak ratio is a complex ratio of the auto (IAA, 
IBB) and cross (IAB, IBA) peak intensities as a function of delay time given by: Ξ ! = !!" ! !!" !!!! ! !!! ! !!!" ! !!" ! ≅ !!"#$! (! − !!)!. 
The data were fit with an 11.1ms time offset (t0), which was determined by globally fitting the 
most intense residues from EmrE complexes with each of EtTPP+, TPP+, and MBTPP+ with a 
global time offset and individual rates between ligands.  This delay time offset matches the 
calculated back-transfer time in the pulse sequence, confirming that exchange during back 
transfer must be accounted for with these short ZZ delay times and relatively fast exchange 
rates(28).  This does not affect the determined rate for EmrE-ligand complexes with slow 
exchange rates, as exemplified by EmrE-DPhTPP+, which fit with kconf = 0.4 ± 0.1 s-1 with or 
without the time offset. However, exchange during back transfer is significant for faster 
exchanging complexes when the back-transfer time is comparable to the ZZ delay with fitted 
rates of 30 ± 6 vs. 25 ± 5 s-1 for EtTPP+, 14 ± 3 vs. 13 ± 3 s-1 for MBTPP+, and 4.7 ± 0.5 vs. 4.4 ± 
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0.4 s-1 for TPP+ when determined without or with time offset, respectively.  The quality of the fit 
improved when the time offset was included for these ligands, as judged by reduced residuals.  
The residues used for the global fits for each ligand-bound EmrE sample were: 9, 26, 58, 77, 80, 
82, 83, 106 for EtTPP+; 10, 17, 26, 49, 58, 79, 80, 82, 83, and 106 for MBTPP+; 9, 80, 82, 83, 
and 90 for DPhTPP+; 58, 80, 82, 106, and 108 for DQ2+; and 17, 26, 58, 80, 82, 83, 106 for PP2+.  
The standard deviation of the collective individual fits was used to estimate the error of the 
global fits for each ligand-bound sample. 
The relaxation properties of EmrE reconstituted into isotropic bicelles are not conducive 
to long experiments.  As a result, at delay times past 300ms the signal-to-noise was too low to be 
usable, which limits the accuracy of the rate constant determined for EmrE bound to DPhTPP+, 
the slowest under exchange conditions, as reported in the text. 
The natural abundance 15N of the planar ligands caused significant streaking, which 
prevented the use of cryo probes.  The dynamic properties of EmrE bound to these same ligands 
made the ZZ-exchange data analysis difficult.  Due to these factors, EmrE bound to Eth+ could 
not be analyzed quantitatively.  Better quality spectra were obtained for EmrE bound to PP2+ in 
DMPC/DHPC rather than DLPC/DHPC bicelles.  Therefore, the rate is reported under these 
conditions since the conformational exchange rate of EmrE bound to TPP+ does not change 
between DLPC and DMPC bicelles (Table 1, Fig. 7). 
Spectra for lineshape analysis were processed with exponential line broadening to 
maintain a Lorentzian lineshape.  Analysis was carried out by first extracting integrated 1D slices 
of TPP+- and DPhTPP+-bound EmrE from 1H/15N TROSY HSQC spectra using the IDAP 
Sparky extension (Integrative Data Analysis Platform, IDAP; 
http://kovrigin.chem.mu.edu/IDAP/) (29).  The 1H lineshapes for all ligand-bound samples were 
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fit to the analytical solution of the two-state Bloch-McConnell equations with equal populations 
in each state (30).  The peak positions (ωA, ωB) and intrinsic relaxation rates (RoA, RoB) were set 
as adjustable parameters, while the conformational interconversion rate (kconf) was held using the 
value determined by ZZ-exchange spectroscopy.  1D slices from MeTPP+-bound EmrE spectra 
were extracted in the same manner and fit with the separation between the chemical shift 
endpoints (Δω) and intrinsic linewidth values constrained based on the results of the TPP+- and 
DPhTPP+-bound EmrE fits.  Where values varied between ligands, the fitting parameter was 
allowed to float within constraints that spanned the entire range of values to allow for differences 
in chemical shift and intrinsic linewidth between ligands.  To determine the conformational 
exchange rate, MeTPP+-bound EmrE lineshapes were globally fit with a single kconf and 
individual Δω, RoA, and RoB.  The global fits was performed using 12 residues: Y6, G9, G26, 
W31, S43, L47, Q49, Y53, F78, R82, G90, and L103.   
Chemical shift differences (Δδtot) were calculated as a weighted average of the 
differences in amide proton (ΔδH) and nitrogen (ΔδN) chemical shifts with respect to TPP+-bound 
EmrE (31): ∆!!"! = ∆!! !+ 0.154∆!! !. 
Since MeTPP+-bound EmrE only has a single set of peaks, the chemical shift difference was 
taken with respect to the average of the two TPP+ peaks for each residue. 
 The energetic barrier to conformational interconversion was estimated using transition-
state theory: ∆!!"#$‡ = −!"#$ !!!"#$!!! , 
where R is the universal gas constant, T is the temperature, h is Planck’s constant, kconf is the 
conformational exchange rate determined via NMR methods, and kB is the Boltzmann constant. 
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RESULTS 
Multidrug recognition and efflux by EmrE—EmrE binds a wide variety of polyaromatic 
cation substrates. In order to dissect key ligand properties, we began by examining a simple 
series of five compounds that all share a +1 charge and tetrahedral geometry and differ only by 
substitution of one phenyl ring: TPP+, MeTPP+ (also known as TPMP+), EtTPP+ (also known as 
TPEP+), DPhTPP+, and MBTPP+ (Fig. 1A, Table 1).  Since this simple chemical series has not 
been previously studied, we first confirmed that these compounds are substrates of EmrE based 
on direct binding experiments via isothermal titration calorimetry (ITC) and in-cell efflux assays.   
We used ITC to determine the relative affinity of each of the five tetrahedral substrates 
for EmrE reconstituted into DLPC/DHPC isotropic bicelles.  Surprisingly, the binding affinity 
varies over three orders of magnitude (Fig. 2A, Fig. 3). Upon further inspection, within this 
series of identically charged tetrahedral substrates, binding affinity is roughly correlated with 
enthalpy (Fig. 2B).  In addition, the binding enthalpy is correlated with the hydrophobicity of the 
substrate, as assessed by the measured partition coefficients (Fig. 2C). Multiple mutational 
studies have identified key residues important for substrate binding in EmrE (32-34), and these 
aromatic and hydrophobic residues line the binding site in the crystal structure (35) (Fig. 11C).  
Thus, the data are consistent with hydrophobicity dominating the binding interaction between the 
substrate and the active site, provided other ligand properties are similar. 
To see whether these trends were generalizable to a wider range of EmrE substrates, we 
looked at two planar divalent substrates, PP2+ and DQ2+ (Table 1, Fig. 2A, Fig. 3).  The affinity 
of ethidium+ (Eth+) for EmrE was too weak to be measured quantitatively via ITC, but Eth+ 
clearly binds EmrE with a weaker affinity and lower enthalpy than PP2+ and DQ2+.  Comparison 
between the planar and tetrahedral substrate series suggests that binding affinity is always 
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correlated with enthalpy (Fig. 2B).  However, binding enthalpy does not depend simply on 
substrate hydrophobicity, since ligands with differing charge and geometry do not follow the 
same trend (Fig. 2C). Both charge and geometry may have significant effects on substrate 
binding for two reasons. First, ligand charge will affect the interaction of the substrates with the 
critical residue Glu 14 in the binding pocket. Second, the structure of EmrE, and thus its binding 
pocket architecture, is known to change in order to accommodate different substrate geometries 
(2). Therefore, multiple ligand properties affect the structure of the transporter-substrate complex 
and substrate binding affinity. 
It is important to investigate how this all comes together in the context of the cell.  An in 
vivo assay allows us to monitor the competitive efflux of Eth+ and the tetrahedral substrates in E. 
coli (Fig. 4).  Cells overexpressing EmrE efflux Eth+ considerably faster than control cells (Fig. 
4A, dashed and solid orange lines, respectively), indicating that a significant portion of the active 
efflux is due to EmrE.  Cells are unable to efflux Eth+ in the absence of a proton gradient (Fig. 
4A, orange line, ‘+CCCP’).  The non-EmrE-driven efflux rate is independent of the identity of 
the competing substrate, with the exception of DPhTPP+ (Fig. 4A).  On the other hand, cells 
over-expressing EmrE have a decrease in Eth+ efflux when one of the TPP+-derivatives is added 
(Fig. 4B).  All five of the tetrahedral substrates compete with Eth+, indicating that they are 
transported by EmrE in its native E. coli environment. The effect varies with the substrate, 
demonstrating that the in vivo transport rate depends on the identity of the bound substrate 
(Table 1: ‘relative transport’). This is not simply blockage by binding of competing substrate to 
the transport pore, since the effect does not correlate simply with binding affinity (Table 1) and 
MeTPP+ even enhances the final extent of ethidium efflux (Fig. 4B, red line).  
92
Differences in the overall transport rate may be a result of changes in several steps in the 
transport cycle. Both substrate off-rate and conformational exchange rate have been suggested as 
likely candidates for rate-limiting steps for EmrE transport.  Off-rates have been determined 
previously for several substrates of EmrE (7), but the rate of conformational exchange has only 
been measured for TPP+ (14). Therefore, we directly measured the rate of this important step for 
all the substrates in our ligand series using NMR.  
Multidrug conformational exchange—Large-scale global motion, such as exchange 
between the inward- and outward-facing states of EmrE, can be directly monitored using solution 
NMR dynamics methods. 15N/1H TROSY HSQC spectra of EmrE bound to EtTPP+, MBTPP+, 
and DPhTPP+ indicate that EmrE bound to these compounds has the same two sets of peaks 
previously described for TPP+-bound EmrE (Fig. 5) (14). This corresponds to the two monomers 
in an asymmetric dimer, with inward- to outward-facing transitions occurring via AB-to-BA 
exchange as predicted by Fleishman, et al. (5) (Fig. 1B).  The overall pattern of the peaks is 
similar in each case, indicating the same overall fold.  However, local chemical shift changes do 
occur and are discussed below.  Qualitatively, the different extent of line-broadening in each 
spectrum results from differences in the conformational exchange timescale. This rate is 
quantified using TROSY-selected ZZ-exchange experiments (22), as demonstrated previously 
for TPP+-bound EmrE (14) (Fig. 6).  The data are presented in the style of Miloushev, et al. (27), 
which allows easy comparison of global exchange between different substrate-bound states (Fig. 
7, Fig. 10A, Table 1).  It is clear that the rate of conformational interconversion varies 
significantly with the identity of the bound substrate. 
Amazingly, when EmrE is bound to the remaining member of the series, MeTPP+, it 
reveals only a single set of peaks in a 15N/1H TROSY HSQC (Fig. 8A). Thus, when bound to this 
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substrate, EmrE is pushed into intermediate-fast exchange. Under these conditions, each peak 
represents the average chemical shift of the exchanging states for each residue, and lineshape 
analysis is used to extract the conformational exchange rate. This requires prior knowledge of the 
chemical shift difference between the two states in the absence of exchange and the intrinsic 
linewidths.  We determined these parameters by fitting the lineshapes for EmrE bound to TPP+ 
and DPhTPP+ using the known conformational exchange rates determined by ZZ-exchange 
spectroscopy as described in the methods.  Since EmrE in complex with these two substrates has 
the slowest exchange rates, these will be the closest to exchange-free conditions and thus have 
the lowest extrapolated error.  By fitting data sets for multiple substrates, we were able to 
determine which parameters are sensitive to substrate identity and adjust the constraints and error 
bars appropriately. The MeTPP+-bound lineshapes of 12 residues were then fit globally to 
determine the conformational exchange rate (Fig. 8B,C). 
The rate of conformational exchange for EmrE bound to the two planar substrates was 
also quantified (Table 1, Fig. 7, Fig. 9). Interestingly, even though the two planar substrates are 
structurally dissimilar, they have quite similar conformational exchange rates.  This is in contrast 
to the large variation within the tetrahedral substrate series. Overall, the conformational 
interconversion rate of substrate-bound EmrE varies over almost three orders of magnitude (Fig. 
10A, Table 1).  How can EmrE move between its inward- and outward-facing states with such 
greatly varying kinetics? Since these are slow dynamics overall, are they an important factor in 
transport rate?   
Previous measurement of several substrate on- and off-rates for detergent-solubilized 
EmrE suggests that substrate association rate is diffusion-limited and dissociation determines 
affinity (7). Using a the on-rate at pH 7 (7) corrected for the temperature dependence of diffusion 
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and our measured binding affinities (45°C, pH 7), we calculated off-rates for each substrate.  The 
estimated off-rates are within an order of magnitude of the conformational exchange rate for all 
but one substrate.  Thus, both processes may contribute to the overall turnover rate for EmrE 
with the rate-limiting step depending on the transported substrate. Future experiments to test this 
hypothesis will require precise measurements under identical conditions. 
The significant differences in conformational exchange rate (kconf) when EmrE is bound 
to different substrates indicate that substrate binding alters the energy landscape. This is 
illustrated in Fig. 10B by approximating the complex energy landscape as a simple two-state 
process along a single reaction coordinate. Compared to TPP+, most of the substrates lead to 
faster conformational exchange rates in EmrE. A faster exchange rate may be due to higher 
ground-state (substrate-bound state) energy, lower transition-state energy for the conformational 
exchange process, or some combination thereof. To distinguish the relative importance of these 
effects, the apo state of the protein provides a convenient substrate-independent reference state to 
anchor the energy landscape. This approximation assumes that differences in the free energy of 
the unbound ligand are small relative to the binding energy.  Differences in ground-state energy 
of EmrE bound to different substrates are determined relative to the apo reference state by the 
free energy of binding (ΔGbind) as calculated from the experimentally determined binding 
affinities (Fig. 10B, left side).  This highlights the significant effect of substrate identity on the 
free energy of the complex, which is particularly interesting in light of the known changes in 
EmrE structure when bound to different substrates (2).  
We then used transition-state theory and the conformational exchange rate determined by 
NMR to estimate the height of the transition-state barrier (ΔG‡conf) relative to the ground state for 
each of the substrates (see methods).  It is clear that both the ground and transition states are 
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affected by bound substrate (Fig. 10B). This is why there is not a simple correlation between 
binding affinity and conformational exchange rate across all substrates (Table 1), as would be 
expected if only the ground-state energy (free energy of substrate-bound EmrE) were affected by 
substrate identity and the transition-state energy was the same for all ligands. Within the 
tetrahedral series, there is less variation in the transition-state energy than in the ground state 
energy (note in particular the clustering of the transition-state energy for MeTPP+, DPhTPP+, 
TPP+, and EtTPP+ despite their wide variation in bound-state energy), and there is general 
correlation between binding energy and exchange rate within this subset. This suggests that the 
protein is an important but not exclusive factor in determining the energy of the conformational 
exchange transition state.  Substrate properties also affect this barrier height, particularly when 
there are differences in substrate charge and geometry (note the higher barrier for the same 
ground state for the +2 planar substrates vs. MeTPP+).  It is this combination of effects that keeps 
the energy barrier for conformational exchange from becoming too large and enables EmrE to be 
a multidrug transporter. 
 
DISCUSSION 
Structural implications—Structural studies have given some insight into the mechanism 
of multidrug recognition in EmrE.  The first three transmembrane helices from each monomer 
come together to form a hydrophobic binding pocket, while the two TM4 helices form a 
dimerization arm (35, 36).  The correlation we observe between ligand hydrophobicity and 
binding affinity within the tetrahedral substrate series confirms the importance of this property 
for substrate interaction with the hydrophobic binding pocket. However, this correlation does not 
hold across more diverse substrates (Fig. 2B,C), indicating that ligand charge and shape are also 
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important for substrate recognition by EmrE. Low-resolution cryo-EM data indicate that the 
structure of EmrE changes when bound to tetrahedral TPP+ and three planar substrates (Eth+, 
PP2+, and DQ2+) (2). Thus, multidrug binding by EmrE results from a complex interaction 
between substrate and protein, with ligand properties affecting the structure of the binding site 
and the free energy of the complex. Since helix tilt depends on the identity of the substrate, and 
the helices must reorient for alternating access, structural and dynamic changes are likely to be 
linked. 
Throughout these experiments, we observed how relatively small differences in the 
substrate cause large changes in binding, dynamics, and functional transport by EmrE.  Hints at 
the structural changes induced in EmrE by the different substrates are provided by chemical shift 
changes in the 15N/1H TROSY HSQC spectra (Fig. 11A,B).  Residues in TM1 such as A10, G17, 
and I11 that affect substrate binding and specificity (32, 37) (Fig. 11C) show significant shifts 
between EmrE bound to TPP+ and the four other related compounds as expected for residues in 
close proximity to the substrate.  I94 and V98 are thought to form a “pivot point” in TM4 of the 
SMRs with importance not only for dimerization, but also a direct role in the mechanism of 
multidrug efflux (38).  While I94 is not assigned, V98 does shift with substrate.  Interestingly, 
V98 has very large shifts in one state and negligible shifts in the other, indicating an asymmetric 
role for this residue. In the crystal structure, V98 from one monomer faces into the interface 
between the two TM4 helices near the TM3 kink, while in the other monomer it is rotated into a 
more outward-facing position.  The kink in TM3, caused by the GVG motif (residues 65-67), is 
also expected to play a key role in conformational interconversion (5, 14, 39), and this kink 
changes conformation upon substrate binding, as shown by solid-state NMR PISEMA spectra of 
V66 and V69 (40).  Intriguingly, this region has some of the largest chemical shift changes when 
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different substrates are bound, suggesting an important role for this hinge region in translating 
substrate identity into distinct rates of exchange for the common conformational interconversion 
process. 
Further inspection of the spectra highlights some unique features of the C-terminal region 
of EmrE. The C-termini are missing from the crystal structure (35), indicating they do not have a 
single well-defined conformation under those conditions.  However, residues in this region, 
including 104-108, have unique, well-resolved chemical shifts that do not match random coil 
chemical shifts, indicating that the C-terminus is not simply a floppy tail. In agreement with EPR 
studies that show a loss in helical periodicity after residue 103 (39), these chemical shifts are not 
typical of helical secondary structure, as might be expected if the final helix extended beyond the 
point where it is resolved in the crystal. Additionally, at least one of each pair of peaks for 
residues 105, 106, and 108 is highly sensitive to bound substrate (Fig. 11A). Arginine 106 (Fig. 
5) provides a particularly well-resolved example of the behavior of residues in this region. 
Examination of the crystal structure reveals that on the open face of EmrE, the entrance to the 
transport pore extends between the TM3 helices (Fig. 1B) and there is space for C-terminal 
residues from monomer A to extend into this region. Using differential water accessibility to 
identify monomers A and B (14), it is precisely the peaks corresponding to the C-terminal tail of 
monomer A that are sensitive to substrate identity. Although its exact role is not known, the C-
terminus of EmrE is as sensitive to bound substrate identity as other key regions of EmrE and 
should not be ignored when considering the structure and function of the protein despite its 
absence in the crystal structure. 
Implications for protein dynamics—The importance of protein motions on different 
timescales for biological function is well-established (41, 42).  The large-scale inward- to 
98
outward-facing conformational change of EmrE is key to the biological activity of this multidrug 
resistance transporter.  As we have shown, the dynamics of this large-scale structural change are 
modulated over several orders of magnitude by the identity of the substrate being transported.  
Global domain motions that are modulated (in a non switch-like fashion) to this extreme have 
not been extensively reported.  Only one similar example of a transporter exists: LeuT 
interconversion dynamics differ when bound to either alanine or leucine (43).  However, the 
differences in rates do not vary as significantly as reported here, and the extreme differences in 
rate observed for EmrE may reflect the unique properties required for multidrug recognition and 
transport. Thus, we propose that large changes in dynamics with substrate identity may occur in 
many MDR transporters.  
The coupled effects of substrate binding on EmrE structure and dynamics provide 
important insight into the transport mechanism. For EmrE, our results are consistent with large 
structural differences when bound to diverse substrates (2) leading to significant differences in 
the free energy of the bound state that are dependent on ligand size, charge, and hydrophobicity. 
This bound state is the ground state for the conformational transition between open-in and open-
out states. The observation that there is less variation in the transition state energy within the 
tetrahedral series indicates the importance of EmrE itself in influencing the conformational 
exchange transition.  This is reminiscent of the finding that partially active mutants and 
phosphorylation of NtrC alter the rate of exchange between the active and inactive states of this 
signaling protein by changing the ground-state energy and have very little effect on the transition 
state energy.  Mutations of NtrC residues participating in the transition pathway do affect the 
transition state energy (44).  However, in EmrE, there is structural overlap between the regions 
involved in substrate binding and interconversion. The chemical shift differences between EmrE 
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bound to different substrates (Fig. 11A,B) reveal significant effects in TM3 and TM4. TM3 
forms part of the hydrophobic binding pocket and contains the critical binding residue W63. The 
TM3 kink structure is sensitive to substrate binding (40), and together with the TM4 hinge is 
believed to play a critical role in the conformational interconversion (5, 14, 38, 39).  Based on 
this data, changes in helix tilt upon ligand binding alter the ground-state energy for the complex, 
and can affect the transition-state energy via the effect of altered helix tilt on the TM3-TM4 
hinge point or direct ligand interaction with the TM3 hinge. Thus, we propose that TM3 plays a 
central role in coupling substrate binding to conformational exchange between inward- and 
outward-facing states in EmrE.  
The influence of substrate on the transition-state energy for EmrE converting between 
inward- and outward-facing states is consistent with the alternating-access model of antiport.  
Unlike soluble enzymes, which have frequently been found to pre-sample the enzymatically-
active conformation in the apo state (45-49), EmrE should not undergo transport-related motions 
when not bound to substrate in order to achieve coupled antiport. This is more similar to PKA-C, 
where nucleotide binding is required to achieve a state with both structure and dynamics primed 
for catalysis (50).  For single-site alternating-access antiport, the transition state for 
conformational exchange cannot be determined solely by the protein and must have a significant 
influence from the substrate, in agreement with our data for EmrE.  This suggests a mechanism 
for transport inhibition. A very tight-binding substrate may stabilize the ground state sufficiently 
to create a nearly insurmountable energetic barrier for conformational exchange, thus trapping a 
single state of EmrE and preventing efflux.  
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TABLE 1. Summary of thermodynamics and kinetics of EmrE bound to range of tetrahedral and 
planar ligands.  
 
Ligand Binding 
constant 
(KdpH7, µM)a 
ΔH 
(kJ/mol) 
n Interconversion 
rate (kconf, s-1) 
Relative 
transport
c 
LogP 
MeTPP+ 130 ± 20 -12.7 ± 0.2 0.60 ± 0.04 190 ± 80 1 1.8 ± 0.1 
EtTPP+ 21.8 ± 0.7 -16.6 ± 0.2 0.57 ± 0.04 25 ± 5 2 1.9 ± 0.1 
TPP+ 0.45 ± 0.01 -22 ± 1 0.49 ± 0.05 4.4 ± 0.4 
4.7 ± 0.6 b 
4 2.2 ± 0.1 
DPhTPP+ 0.16 ± 0.02 -39.4 ± 0.3 0.53 ± 0.05 0.4 ± 0.1 5 3.0 ± 0.2 
MBTPP+ 0.04 ± 0.01 -38 ± 2 0.544 ± 
0.009 
13 ± 3 3 2.5 ± 0.1 
DQ2+ 100 ± 20 -5.7 ± 0.3 0.58 ± 0.02 11 ± 2 N/A 3.4 ± 0.1 
PP2+ 90 ± 10 -16.3 ± 0.7 0.58 ± 0.06 13 ± 3 b N/A 4.3 +0.5/-
1.0 
 
aObserved binding constant from ITC at pH 7, 45°C. 
bReconstituted into DMPC/DHPC isotropic bicelles. 
cDetermined via in-cell assay.  Ranked 1 through 5, from fastest to slowest EmrE-dependent 
ethidium efflux in the presence of each competing ligand. 
 
101
REFERENCES 
1. Jardetzky, O. (1966) Simple allosteric model for membrane pumps. Nature 211, 969–970 
2. Korkhov, V. M., and Tate, C. G. (2008) Electron crystallography reveals plasticity within 
the drug binding site of the small multidrug transporter EmrE. J Mol Biol 377, 1094–1103 
3. Rotem, D., and Schuldiner, S. (2004) EmrE, a multidrug transporter from Escherichia coli, 
transports monovalent and divalent substrates with the same stoichiometry. J Biol Chem 
279, 48787–48793 
4. Schuldiner, S. (2009) EmrE, a model for studying evolution and mechanism of ion-
coupled transporters. BBA - Proteins and Proteomics, 1–15 
5. Fleishman, S. J., Harrington, S. E., Enosh, A., Halperin, D., Tate, C. G., and Ben-Tal, N. 
(2006) Quasi-symmetry in the cryo-EM structure of EmrE provides the key to modeling 
its transmembrane domain. J Mol Biol 364, 54–67 
6. Yerushalmi, H., and Schuldiner, S. (2000) A model for coupling of H(+) and substrate 
fluxes based on “time-sharing” of a common binding site. Biochemistry 39, 14711–14719 
7. Adam, Y., Tayer, N., Rotem, D., Schreiber, G., and Schuldiner, S. (2007) The fast release 
of sticky protons: kinetics of substrate binding and proton release in a multidrug 
transporter. Proc Natl Acad Sci USA 104, 17989–17994 
8. Henzler-Wildman, K. (2012) Analyzing conformational changes in the transport cycle of 
EmrE. Curr Opin Struct Biol 22, 38–43 
9. Ong, Y.-S., Lakatos, A., Becker-Baldus, J., Pos, K. M., and Glaubitz, C. (2013) Detecting 
substrates bound to the secondary multidrug efflux pump EmrE by DNP-enhanced solid-
state NMR. J Am Chem Soc 135, 15754–15762 
10. Higgins, C. F. (2007) Multiple molecular mechanisms for multidrug resistance 
transporters. Nature 446, 749–757 
11. Wade, H. (2010) MD recognition by MDR gene regulators. Curr Opin Struct Biol 20, 
489–496 
12. Neyfakh, A. A. (2002) Mystery of multidrug transporters: the answer can be simple. Mol. 
Microbiol. 44, 1123–1130 
13. Bachas, S., Eginton, C., Gunio, D., and Wade, H. (2011) Structural contributions to 
multidrug recognition in the multidrug resistance (MDR) gene regulator, BmrR. 108, 
11046–11051 
14. Morrison, E. A., Dekoster, G. T., Dutta, S., Vafabakhsh, R., Clarkson, M. W., Bahl, A., 
Kern, D., Ha, T., and Henzler-Wildman, K. A. (2012) Antiparallel EmrE exports drugs by 
exchanging between asymmetric structures. Nature 481, 45–50 
15. Morrison, E. A., and Henzler-Wildman, K. A. (2012) Reconstitution of integral membrane 
proteins into isotropic bicelles with improved sample stability and expanded lipid 
composition profile. Biochimica et Biophysica Acta (BBA) - Biomembranes 1818, 814–
820 
16. Organization for Economic Co-operation and Development (OECD) (2004) OECD 
guidelines for the testing of chemicals No. 117: “Partition coefficient (n-octanol/water), 
high performance liquid chromatography (HPLC) method.” 1–11 
17. Garbett, N. C., Hammond, N. B., and Graves, D. E. (2004) Influence of the amino 
substituents in the interaction of ethidium bromide with DNA. Biophysical Journal 87, 
3974–3981 
18. Wright, R. G., Wakelin, L. P. G., Fieldes, A., Acheson, R. M., Waring, M. J., (null), 
102
(null), (null), (null), and (null) (1980) Effects of ring substituents and linker chains on the 
bifunctional intercalation of diacridines into deoxyribonucleic acid. Biochemistry 19, 
5825–5836 
19. Glover, K. J., Whiles, J. A., Wu, G., Yu, N., Deems, R., Struppe, J. O., Stark, R. E., 
Komives, E. A., and Vold, R. R. (2001) Structural evaluation of phospholipid bicelles for 
solution-state studies of membrane-associated biomolecules. Biophysical Journal 81, 
2163–2171 
20. Lambert, B., and Le Pecq, J. B. (1984) Effect of mutation, electric membrane potential, 
and metabolic inhibitors on the accessibility of nucleic acids to ethidium bromide in 
Escherichia coli cells. Biochemistry 23, 166–176 
21. Yerushalmi, H., Lebendiker, M., and Schuldiner, S. (1995) EmrE, an Escherichia coli 12-
kDa multidrug transporter, exchanges toxic cations and H+ and is soluble in organic 
solvents. J Biol Chem 270, 6856–6863 
22. Li, Y., and Palmer, A. G. (2009) TROSY-selected ZZ-exchange experiment for 
characterizing slow chemical exchange in large proteins. J Biomol NMR 45, 357–360 
23. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) 
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol 
NMR 6, 277–293 
24. JOHNSON, B., and BLEVINS, R. (1994) NMR VIEW - A COMPUTER-PROGRAM 
FOR THE VISUALIZATION AND ANALYSIS OF NMR DATA. J Biomol NMR 4, 
603–614 
25. Goddard, T. D., and Kneller, D. G. Sparky 3.  
26. Vranken, W. F., Boucher, W., Stevens, T. J., Fogh, R. H., Pajon, A., Llinas, M., Ulrich, E. 
L., Markley, J. L., Ionides, J., and Laue, E. D. (2005) The CCPN data model for NMR 
spectroscopy: development of a software pipeline. Proteins 59, 687–696 
27. Miloushev, V. Z., Bahna, F., Ciatto, C., Ahlsen, G., Honig, B., Shapiro, L., and Palmer, A. 
G. (2008) Dynamic properties of a type II cadherin adhesive domain: implications for the 
mechanism of strand-swapping of classical cadherins. Structure 16, 1195–1205 
28. Tollinger, M., Skrynnikov, N. R., Mulder, F. A., Forman-Kay, J. D., and Kay, L. E. 
(2001) Slow dynamics in folded and unfolded states of an SH3 domain. J Am Chem Soc 
123, 11341–11352 
29. Kovrigin, E. L. (2012) NMR line shapes and multi-state binding equilibria. J Biomol NMR 
53, 257–270 
30. McConnell, H. M. (1958) Reaction Rates by Nuclear Magnetic Resonance. The Journal of 
Chemical Physics 28, 430–431 
31. Tugarinov, V., and Kay, L. E. (2003) Quantitative NMR studies of high molecular weight 
proteins: application to domain orientation and ligand binding in the 723 residue enzyme 
malate synthase G. J Mol Biol 327, 1121–1133 
32. Gutman, N., Steiner-Mordoch, S., and Schuldiner, S. (2003) An amino acid cluster around 
the essential Glu-14 is part of the substrate- and proton-binding domain of EmrE, a 
multidrug transporter from Escherichia coli. J Biol Chem 278, 16082–16087 
33. Elbaz, Y., Tayer, N., Steinfels, E., Steiner-Mordoch, S., and Schuldiner, S. (2005) 
Substrate-induced tryptophan fluorescence changes in EmrE, the smallest ion-coupled 
multidrug transporter. Biochemistry 44, 7369–7377 
34. Rotem, D., Steiner-Mordoch, S., and Schuldiner, S. (2006) Identification of tyrosine 
residues critical for the function of an ion-coupled multidrug transporter. J Biol Chem 281, 
103
18715–18722 
35. Chen, Y. J., Pornillos, O., Lieu, S., Ma, C., Chen, A. P., and Chang, G. (2007) X-ray 
structure of EmrE supports dual topology model. Proc Natl Acad Sci USA 104, 18999–
19004 
36. Ubarretxena-Belandia, I., Baldwin, J. M., Schuldiner, S., and Tate, C. G. (2003) Three-
dimensional structure of the bacterial multidrug transporter EmrE shows it is an 
asymmetric homodimer. EMBO J 22, 6175–6181 
37. Elbaz, Y., Salomon, T., and Schuldiner, S. (2008) Identification of a glycine motif 
required for packing in EmrE, a multidrug transporter from Escherichia coli. J Biol Chem 
283, 12276–12283 
38. Poulsen, B. E., Cunningham, F., Lee, K. K. Y., and Deber, C. M. (2011) Modulation of 
Substrate Efflux in Bacterial Small Multidrug Resistance Proteins by Mutations at the 
Dimer Interface. J Bacteriol 193, 5929–5935 
39. Amadi, S. T., Koteiche, H. A., Mishra, S., and McHaourab, H. S. (2010) Structure, 
dynamics and substrate-induced conformational changes of the multidrug transporter emre 
in liposomes. J Biol Chem 
40. Gayen, A., Banigan, J. R., and Traaseth, N. J. (2013) Ligand-induced conformational 
changes of the multidrug resistance transporter EmrE probed by oriented solid-state NMR 
spectroscopy. Angew Chem Int Ed Engl 52, 10321–10324 
41. Henzler-Wildman, K., and Kern, D. (2007) Dynamic personalities of proteins. Nature 450, 
964–972 
42. Akke, M. (2002) NMR methods for characterizing microsecond to millisecond dynamics 
in recognition and catalysis. Curr Opin Struct Biol 12, 642–647 
43. Zhao, Y., Terry, D. S., Shi, L., Quick, M., Weinstein, H., Blanchard, S. C., and Javitch, J. 
A. (2011) Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter 
transporter homologue. Nature 474, 109–113 
44. Gardino, A. K., Villali, J., Kivenson, A., Lei, M., Liu, C. F., Steindel, P., Eisenmesser, E. 
Z., Labeikovsky, W., Wolf-Watz, M., Clarkson, M. W., and Kern, D. (2009) Transient 
non-native hydrogen bonds promote activation of a signaling protein. Cell 139, 1109–
1118 
45. Henzler-Wildman, K. A., Thai, V., Lei, M., Ott, M., Wolf-Watz, M., Fenn, T., Pozharski, 
E., Wilson, M. A., Petsko, G. A., Karplus, M., Hübner, C. G., and Kern, D. (2007) 
Intrinsic motions along an enzymatic reaction trajectory. Nature 450, 838–844 
46. Labeikovsky, W., Eisenmesser, E. Z., Bosco, D. A., and Kern, D. (2007) Structure and 
dynamics of pin1 during catalysis by NMR. J Mol Biol 367, 1370–1381 
47. Villali, J., and Kern, D. (2010) Choreographing an enzyme's dance. Curr Opin Chem Biol 
14, 636–643 
48. Velyvis, A., Yang, Y. R., Schachman, H. K., and Kay, L. E. (2007) A solution NMR study 
showing that active site ligands and nucleotides directly perturb the allosteric equilibrium 
in aspartate transcarbamoylase. Proc Natl Acad Sci USA 104, 8815–8820 
49. Vogt, A. D., and Di Cera, E. (2013) Conformational selection is a dominant mechanism of 
ligand binding. Biochemistry 52, 5723–5729 
50. Veglia, G., and Cembran, A. (2013) Role of conformational entropy in the activity and 
regulation of the catalytic subunit of protein kinase A. FEBS J. 280, 5608–5615 
 
 
104
P+H3C P+ P+
H3C
P+
O
CH3
O
H3C
P+
CH3
N+
H2N NH2
H3C
N+
CHH3
H3
C
N+
H2N NH2
3
C
N+
CH3H2N
N+
H3C NH2
A
MeTPP+ EtTPP+ TPP+ MBTPP+DPhTPP+
Eth+ PP2+
DQ2+
B
k
k
drug 2H+
drug2H+
periplasm
cytoplasm
90° 90°
A
A
B
B
Figure 1.  EmrE binds and transports a broad range of ligands.  A. Chemical structures of the 
tetrahedral and planar ligand series. B. The EmrE dimer exchanges between an AB and BA 
conformation (state A in green; state B in blue) as it converts between the inward- and outward-
facing conformations. A 90° rotation permits a view of the open and closed faces of EmrE (PDB 
3B5D, PyMOL).  Figure from Morrison and Henzler-Wildman, 2014.
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Figure 2.  Variation in binding affinity of EmrE substrates.  A. Overlay of representative ITC 
binding curves of the five TPP+-derivatives and two planar compounds: MeTPP+ (red), EtTPP+ 
(magenta), TPP+ (black), MBTPP+ (green), DPhTPP+ (blue), PP2+ (orange), and DQ2+ (purple) 
with the fit baseline subtracted. B. Binding affinity is correlated with enthalpy, regardless of 
ligand geometry (tetrahedral in blue triangles, planar in red squares, R2= 0.84).  C. Partition 
coefficients, a measure of ligand hydrophobicity, correlate with enthalpy within the tetrahedral 
ligand series (blue triangles, R2 = 0.89) but not between ligand series.  Figure from Morrison and 
Henzler-Wildman, 2014.
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Figure 3.  Representative ITC titration for each ligand.
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Figure 4.  Ligand identity determines transport rate in E. coli.  In this competitive transport 
assay in E. coli, Eth+ efflux is monitored upon induction of (A) empty vector or (B) EmrE in 
BL21(DE3) with addition of external Eth+ (orange) or the competing ligands MeTPP+ (red), 
EtTPP+ (magenta), TPP+ (black), MBTPP+ (green), and DPhTPP+ (blue).  The data shown is 
from a single batch of cells, to ensure equal protein expression levels between traces.  Results 
were reproducible between batches of cells and were qualitatively similar between two BL21 
cell lines.  In (A) the Eth+ trace from cells over-expressing EmrE is re-plotted as a dashed orange 
line for reference.  Addition of CCCP inhibits Eth+ efflux (A, ‘+CCCP’).  Figure from Morrison 
and Henzler-Wildman, 2014.
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Figure 5.  NMR spectra of EmrE bound to the tetrahedral substrates indicate the same overall 
protein structure but varying dynamics.  15N/1H TROSY HSQC spectra of EmrE bound to 
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peaks per residue corresponding to slow exchange of the asymmetric dimer.  The TPP+-bound 
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Figure 6.   Overlay of a representative ZZ-exchange plane (red) with the 15N/1H TROSY HSQC 
(black) of EmrE bound to each of the tetrahedral ligands: (A) EtTPP+, 45ms; (B) MBTPP+, 
80ms; and (C) DPhTPP+, 200ms.  For TPP+-bound EmrE, see Morrison, et al., 2012.
1H (ppm)
15
N
 (p
pm
)
15
N
 (p
pm
)
111
7.08.09.010.011.0
105
110
115
120
125
130
G90
G9
G80
R82
L83
G8
G26
W31
F79
S43
G17
C
1H (ppm)
15
N
 (p
pm
)
112
DPhTPP+
MBTPP+
TPP+: DMPC isobi
DQ2+ PP2+: DMPC isobi
TPP+
EtTPP+
8
6
4
2
0
0.060.050.040.030.020.010.00
Time (s)
I A
B
I B
A
/(I
A
A
I B
B
-I A
B
I B
A
)
10
8
6
4
2
0
0.160.140.120.100.080.060.040.020.00
Time (s)
0.05
0.04
0.03
0.02
0.01
0.00
0.350.300.250.200.150.100.050.00
Time (s)
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
0.140.120.100.080.060.040.020.00
Time (s)
0.8
0.6
0.4
0.2
0.0
0.140.120.100.080.060.040.020.00
Time (s)
2.0
1.5
1.0
0.5
0.0
0.100.080.060.040.020.00
Time (s)
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
0.060.050.040.030.020.010.00
Time (s)
I A
B
I B
A
/(I
A
A
I B
B
-I A
B
I B
A
)
I A
B
I B
A
/(I
A
A
I B
B
-I A
B
I B
A
)
I A
B
I B
A
/(I
A
A
I B
B
-I A
B
I B
A
)
I A
B
I B
A
/(I
A
A
I B
B
-I A
B
I B
A
)
I A
B
I B
A
/(I
A
A
I B
B
-I A
B
I B
A
)
I A
B
I B
A
/(I
A
A
I B
B
-I A
B
I B
A
)
Figure 7.   Composite peak ratio analysis plotted for each ligand-bound sample.  Each residue 
used in the global fit is plotted in a different color (color-residue relationship does not hold 
across samples).  The solid black line shows the global fit to each ligand-bound form, as summa-
rized in Table 1.  The dashed black line shows the error in the fit, which was taken as the stan-
dard deviation of the individual fits to each residue.
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Figure 8.  EmrE bound to MeTPP+ is in fast exchange. A.  Overlay of 15N/1H TROSY HSQC 
spectra of TPP+-bound EmrE (black) with the temperature titration of MeTPP+-bound EmrE: 
63°C (red), 56°C (orange), 52°C (yellow), 45°C (green), and 40°C (blue).  All MeTPP+-bound 
spectra were collected with d1 = 6s. B. Representative fits from lineshape analysis for residues 
W31 (top) and G90 (bottom) alongside the 15N/1H TROSY HSQC overlay for EmrE bound to 
TPP+ (black), DPhTPP+ (blue) and MeTPP+ (red).C.  Global fit to 12 residues in a lineshape 
analysis of the MeTPP+-bound EmrE data (see methods), giving a fit of kconf = 190 ± 80 s
-1.
7.08.09.010.011.0 1H (ppm)
105.0
110.0
115.0
120.0
125.0
130.0
15
N
 (p
pm
)
A
650064006300
Chemical shift (Hz)
62006100
Chemical shift (Hz)
9.209.30
118.5
119.0
119.5 W3115
N
 (p
pm
)
1H (ppm)
8.708.808.90
107.0
107.5
108.0
G9015
N
 (p
pm
)
1H (ppm)
C
114
7.
0
8.
0
9.
0
10
.0
11
.0
H
 (p
pm
)
10
5.
0
11
0.
0
11
5.
0
12
0.
0
12
5.
0
13
0.
0
N (ppm)
Figure 9.  NMR spectra of EmrE bound to the tetrahedral and planar substrates indicate the 
same overall protein structure but varying dynamics.  Overlay of TPP+-bound EmrE (black) with 
EmrE bound to the two planar ligands, PP2+ (DMPC bicelles; orange) and DQ2+ (purple). All 
spectra were collected identically at pH 7 and 45°C.
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Figure 10.  Substrate identity determines rate of EmrE conformational exchange.  A. Composite 
peak ratio analysis of ZZ-exchange data shows significantly different exchange rates for EmrE 
bound to TPP+ (black) and the other slow-exchanging derivatives, EtTPP+ (magenta), MBTPP+ 
(green), and DPhTPP+ (blue).  Global fits are depicted with solid lines, along with data points for 
several representative residues from each ligand.  The dashed red line corresponds to a simula-
tion of the composite peak ratio of MeTPP+ using the rate of conformational interconversion 
determined via lineshape analysis (Fig. 8).  B.  A simplified energy diagram illustrates the 
connection between ligand-binding (left) and conformational exchange between the open-in 
(AB) and open-out (BA) states of ligand-bound EmrE (right).  The free energy of binding, Δ
Gbind, was calculated from measured binding affinities.  The dashed lines indicate that nothing is 
known about the transition state connecting the apo and bound states of EmrE.  The two ligand-
bound ground states (AB and BA) have equal energy and are separated by the transition state, ‡, 
with energetic barrier of height ΔG‡conf calculated from the rates of conformational interconver-
sion and transition state theory.  The same ligand color scheme is used as in (A) for the tetrahe-
dral ligands, with the addition of the planar substrates DQ2+ (purple) and PP2+ (orange).
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Figure 11.  Chemical shift differences highlight important functional residues.  A. Chemical 
shift changes between TPP+-bound EmrE and EmrE bound to other TPP+-derivatives (MeTPP+, 
red; EtTPP+, magenta; DPhTPP+, blue; MBTPP+, green).  States A and B are distinguished via 
the dark and light shades, respectively.  Due to a lack in connectivity, state A vs. B is not known 
for residues 17, 31, 67, 98, and 108.  The asterisk (*) indicates that the peak moves significantly, 
but the exact assignment is uncertain.  Residues with no data indicate a lack of transferred 
assignment.  The approximate secondary structure according to the crystal structure is shown at 
the top and includes symbols to allow easy comparison with (C).  B. Chemical shift differences 
between MBTPP+- and TPP+-bound EmrE, plotted onto the TPP+-bound structure (PDB 3B5D, 
PyMOL) reveal regions sensitive to ligand identity.  Residues in grey indicate a lack of data.  C. 
EmrE topology diagram highlighting specific functional regions of EmrE based on previously 
published mutagenesis studies: direct substrate binding and substrate specificity (black), TPP+/H+ 
coupling (grey), GVG helix kink motif (cyan), and GG7 dimerization motif (purple, squares 
represent “pivot point”).  Figure made using TOPO2 (http://www.sacs.ucsf.edu/TOPO2/).
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Chapter V.  Conclusion and Future Directions. 
 
My thesis studies have focused on the transport mechanism of the small multidrug 
resistance transporter EmrE.  Biophysical investigations required that EmrE be reconstituted into 
a membrane mimetic environment that produced reproducible, long-lived samples that would be 
stable at elevated temperatures for extended periods of time.  I optimized a protocol for the 
reconstitution of EmrE into isotropic bicelles, or small bilayer discs that are capped off by short-
chain lipid.  Isotropic bicelles preserve a native bilayer environment, while meeting the fast-
tumbling requirements for solution NMR.  In addition, the optical clarity of these bicelles makes 
them suitable for absorbance and fluorescence measurements.  Although I only carried out 
extensive studies in a limited lipid composition, I found that the protocol allowed for EmrE to be 
reconstituted into bicelles with a variety of lipid compositions, including mixtures of synthetic 
lipids and even E. coli lipid extract.  Interestingly, comparison of 15N/1H TROSY HSQC spectra 
of TPP+-bound EmrE reconstituted in an assortment of these lipid compositions indicated that 
EmrE has the same overall structure in each of these environments, but with local structural 
changes and potential changes in dynamics that would be an interesting avenue of exploration for 
future studies in the lab. 
 Using this optimized system, we made the first direct observation of conformational 
exchange between the inward- and outward-facing states of TPP+-bound EmrE.  This study is 
among the first of functional transport motions in the literature, with others including single-
molecule FRET work on the sodium-dependent amino acid transporters LeuT and GltPh1-3.  Our 
investigations provided support for Fleishman’s model of exchange between AB and BA 
conformations in an asymmetric, antiparallel homodimer4.  We directly quantified this 
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conformational interconversion, and confirmed that the two low-energy conformations being 
observed were indeed structures that were only open to one side of the membrane at a time, as 
required by the single-site alternating-access model for transport.  In Fleishman’s model, the two 
monomers swap states within the dimer such that, although the dimer is asymmetric, the open-in 
and open-out structures are related by a two-fold axis of symmetry within the membrane bilayer.  
Two-fold symmetry and inverted repeats, which is essentially dual topology of two domains 
within a monomeric protein, are common themes within the transporter field5,6.  As analyzed in 
detail for the prolific LeuT fold, inverted repeats inherently have pseudo-two-fold symmetry 
axes in the bilayer plane5, and the SMRs are likely to be another family with this global property.  
Dual repeats and two-fold exchange symmetry within the membrane bilayer is an elegant way to 
arrive at two low-energy conformations4, the inward- and outward-facing conformations of the 
alternating-access mechanism for transport. 
 How is this elegant mechanism for conformational exchange by a dual topology protein 
exploited by EmrE to carry out multidrug transport?  EmrE recognizes a diverse range of 
polyaromatic cations and binds these substrates with affinities ranging over many orders of 
magnitude.  Even what seems like a small change in ligand structure, such as the substitution of a 
single position in a tetrahedral compound, has a profound impact on binding, conformational 
interconversion, and transport function.  How can this be?  We know that ligand hydrophobicity 
has a strong effect on binding enthalpies, which in turn is positively correlated with binding 
affinity.  We also know that cryoEM projection maps suggest a difference in conformation/helix 
tilt between one tetrahedral and three planar ligands7.  Thus, there are several contributing factors 
affecting the energetics of the system: direct protein-ligand interactions and structural changes 
that alter the architecture of the binding site and mechanistic hotspots.  Using apo EmrE as the 
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common reference state and assuming relatively small differences between the energies of the 
unbound substrate, it is clear that substrate binding lowers the ground state energy to different 
extents (see Fig. 10B of Chapter 4).  However, by using transition-state theory to calculate the 
barrier height to interconversion for each EmrE-substrate complex, it is clear that substrate 
identity also differentially affects the transition state.  A functional antiporter cannot interconvert 
in its truly apo form.  Thus, ligand binding must lower the transition state significantly.  
However, the transition state is not the same between different EmrE-substrate complexes.  In 
such a small transporter, the binding site overlaps with structural regions important for 
interconversion, so the effects of substrate on these two aspects of function (binding and 
conformational exchange) are convoluted.  What initially seems like a small change in ligand 
structure, such as the substitution of a methyl group for a phenyl group in a tetrahedral 
phosphonium compound, actually has a large effect on hydrophobic interactions with the binding 
site.  Because the binding site overlaps with hotspots involved in interconversion, these changes 
in ligand also manifest themselves as changes in conformational exchange, albeit to a lesser 
extent.  For more dramatic changes in ligand structure, such as moving from a tetrahedral, +1 
ligand (e.g. TPP+) to a planar, +2 ligand (e.g. PP2+), changes in the helix tilt have a clearer impact 
on the interconversion hotspots. 
My thesis work has focused on the conformational interconversion of EmrE when bound 
to a polyaromatic cation substrate, as this is the step that moves the drug across the membrane 
barrier and provides the most insight into multidrug recognition.  However, the proton side of the 
transport cycle is key to understanding how EmrE couples the efflux of drug to its energy source.  
We are currently working to fill in the mechanistic details of the full transport cycle (Fig. 1). 	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Further investigation into the mechanism of multidrug transport: Drug binding is coupled 
to proton antiport. 
 The proton gradient across the inner membrane is the energy source for polyaromatic 
cation drug efflux by EmrE.  The TM helices of integral membrane proteins are largely 
hydrophobic to stabilize interactions with neighboring TM helices and the surrounding lipid 
membrane.  However, transporters of ions and charged compounds require polar and charged 
residues to coordinate these substrates along the translocation pathway8. EmrE only has one 
charged residue within the TM helices—the highly conserved glutamate 14, which binds proton 
or polyaromatic cation substrate.  The other seven charged amino acids are found in loop regions 
or ends of helices and can be mutated to cysteine without affecting function9,10.  The Schuldiner 
lab has shown via mutagenesis and reactivity with the carbodiimide DCCD, which inactivates 
the protein, that E14 is critical for transport activity 9,10.  E14 is the basis of the proton-drug 
coupling mechanism of the single-site alternating-access model of transport. 
Based on data published to date, EmrE has been thought to bind either two protons or 
one substrate molecule8,11 and to have a strict 2H+:1 polyaromatic cation transport 
stoichiometry12.  Drug binding and transport activities are strongly dependent on pH.  The 
tightest drug binding occurs at high pH where there are fewer competing protons13.  Substrate 
binding stimulates proton release, and rates of substrate binding and substrate-induced release of 
protons are faster at higher pH14. 
Understanding how substrates with a charge of +1 vs. +2 are transported will help to 
understand how proton and drug transport are coupled.  Based on assays carried out on EmrE in 
E. coli and reconstituted into liposomes, Schuldiner and co-workers claim that transport 
stoichiometry is always 2H+:1 drug, regardless of substrate charge12 (Fig. 2A).  EmrE provides 
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resistance to E. coli against both TPP+ and methyl viologen2+ (MV2+) in the presence of a pH 
gradient12.  However, when the pH gradient is replaced by an electric potential, EmrE only 
provides resistance against the +1 ligand12.  Similarly, in liposomes, EmrE can transport TPP+ but 
not MV2+ when the driving force is an electric potential12.  Schuldiner and co-workers claim that 
these results imply that transport of TPP+ is electrogenic but transport of MV2+ is 
electroneutral12.  However, just because something can happen, doesn’t mean that it must 
happen.  One could envision that the two E14 residues of an EmrE dimer could coordinate: 1 × 
+2 ligand, 1 × +1 ligand, 1 × +1 ligand + 1 × H+, or 2 × H+ (Fig. 2A, B). 
I have performed ΔpH-driven PP2+- and TPP+-transport assays on EmrE reconstituted 
into liposomes (Fig. 3).  If transport were electrogenic, a charge gradient would quickly build up 
that would halt transport.  Addition of the K+-ionophore valinomycin would dissipate this 
gradient and re-start transport.  However, in my assays, ΔpH-driven transport of both the +1 and 
+2 charged ligand proceeded independently of valinomycin.  Thus, an electric potential was not 
built-up during the transport of TPP+.  Perhaps EmrE can transport a +1 charged ligand 
electroneutrally (1H+:1 drug stoichiometry) or electrogenically (2H+:1 drug stoichiometry), 
depending on which driving forces are present. 
 Future experiments are planned that will employ ITC in order to probe the linkage 
between proton and TPP+ binding.  We will perform ITC titrations of TPP+ binding to EmrE at a 
range of pH values.  Proton-linked equilibria are challenging to study because protons also bind 
buffers.  In order to tease apart the binding of protons to buffer and protein, these titrations will 
be carried out in a range of buffers15,16.  In the end, a combination of titrations performed at 
different pH values and buffer conditions will provide the intrinsic binding constants for TPP+ 
and proton and determine whether a proton and TPP+ are capable of binding EmrE 
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simultaneously, as in Fig. 2B.  The intrinsic binding constant for protons is of course related to 
the pKa of E14. 
 The pKa of E14 is elevated in EmrE in order to couple transport to the proton gradient at 
physiological pH values.  Current estimates from the literature put the value between 7.3 and 
8.513,14,17.  Canonical pKa values for Asp and Glu lie in the range of 3.90 and 4.35, respectively, 
based on titrations on the blocked tripeptide Ac-Ala-Asp(Glu)-Ala-NH218.  Measured pKa values 
for surface-exposed acidic residues in the model soluble protein staphylococcal nuclease (SNase) 
are similar to those values, and some are even depressed18.  How can the pKa of E14 lie around 
physiological pH?  The affect of burying an ionizable residue in the hydrophobic interior of a 
protein has been investigated in SNase.  Elevated pKa values were measured for glutamates 
buried at over 20 positions, with values ranging from 5.2-9.4 and an average of 7.719.  These 
acidic residues can be stably accommodated within the hydrophobic protein interior without 
causing any major structural changes by increasing the probability of protonation 19. 
 We will also attempt to measure the pKa of E14 using NMR.  The pH-dependent ITC 
experiments will provide the pKa value(s) of EmrE, but NMR will allow us to directly observe 
E14.  NMR determinations of pKa come with their own challenges.  If the resonances for E14 in 
states A and B are overlapped, we will not be able to analyze their chemical shifts.  In addition, 
specifically labeled glutamate samples are expensive and difficult to make due to amino acid 
scrambling.  With the high resolution that this technique affords, we will hopefully be able to 
determine whether the two E14 within the dimer are truly symmetric, as suggested in the 
literature20.  I hypothesize that the two active-site E14 residues are asymmetric, but that both 
have highly elevated pKa values. 
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Further investigation into the mechanism of multidrug transport: Drug binding. 
One of my current aims is to further pursue the questions of multidrug transport brought 
up in Chapter 4.  It is clear that binding affinity, the rate of the open-in to open-out 
conformational exchange, and transport rate all depend on the identity of the bound substrate.  
What is (are) the rate-limiting step(s) of transport?  According to the single-site alternating-
access model for antiport (Fig. 1), ligand association, ligand dissociation and conformational 
interconversion are candidates.  Pre-steady-state kinetic studies of the binding of three different 
ligands to EmrE suggest that binding is diffusion-limited14, which leaves ligand dissociation and 
the open-in to open-out transition.  We used our substrate binding constants measured via ITC, in 
conjunction with ligand association rates based on Schuldiner’s studies in detergent14 and 
corrected for the temperature dependence of diffusion, to estimate dissociation rates for five 
tetrahedral ligands (Chapter 4).  According to these calculations, dissociation rate is within an 
order of magnitude of the rate of conformational exchange for all but one ligand.  Thus, both 
steps are likely to contribute to transport, and precise measurements of dissociation rates are 
required. 
There are several processes involved in the transport mechanism of EmrE that could 
convolute an attempt to determine ligand association and dissociation rates, such as proton 
binding, dimerization, and conformational exchange process(es).  Previous attempts at 
reproducing the stopped-flow experiments of Schuldiner and co-workers14 for EmrE 
reconstituted into isotropic bicelles revealed that the data could not be fit to the simple 
mechanism of a single binding event.  Attempts to push the system toward a fully-dimerized, 
fully-deprotonated state to focus on ligand on/off resulted in substrate binding reactions that 
were largely lost in the instrument deadtime.   
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My current approach is to take one of the competing process, protein dimerization, out of 
the equation.  We are using methyl CPMG NMR experiments to measure ligand association and 
dissociation rates of MeTPP+-EmrE at pH 7.  This technique allows us to directly monitor 
natural-abundance 13C of the ligand in the presence of unlabeled, fully-dimerized EmrE.  We 
have collected data sets for 25 and 45°C at two ratios of free:bound ligand.  Comparison of the 
ratio of off- and on-rates measured via methyl CPMG at 45°C to the dissociation constant 
measured via ITC under the same conditions will provide a check for the validity of this method.   
The benefit of this NMR technique is that it allows us to directly follow the ligand.  
However, MeTPP+ is the only substrate that can be studied using methyl CPMG NMR because it 
is the only ligand with an isolated methyl spin system.  MeTPP+ will be used to bridge the two 
techniques.  We can use the CPMG data to establish a well-defined system for stopped-flow 
kinetics studies of fully-dimerized EmrE (determined from measurements of dimerization 
constant by S. Dutta) at pH 7 and 25°C.  Once the system is established, we can proceed to 
measure the on/off rates of other ligands. 
 
Conclusion. 
 The overall aim of my research is to understand the complete transport cycle of the small 
multidrug resistance transporter EmrE (Fig. 1).  My thesis work focused on the global exchange 
between the inward- and outward-facing conformations of EmrE (Fig. 1, bottom row) when 
bound to diverse substrates.  The remaining steps to be addressed are the association and 
dissociation of substrates (protons and polyaromatic cation) and the conformational exchange of 
protonated EmrE (Fig. 1, top row). 
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Figure 1.  Transport cycle for EmrE.  EmrE interconverts between outward- and inward-facing 
states when bound to substrate (proton, top or drug, bottom).  The two states have equal popula-
tions, thus, the forward and reverse rates are identical when a given substrate is bound.  Either 
two protons or a single polyaromatic cation binds EmrE at one time.  Figure from Henzler-
Wildman, K. A. Curr Opin Struct Biol 22, 38-41 (2012).
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Figure 2.  Possible schemes for the binding of two different ligands (X or Y) to protein (E, the 
EmrE dimer).  The Schuldiner lab proposes that only two protons (Y) or one polyaromatic cation 
(X) can bind, independent of substrate charge, supporting scheme (A).  However, my data 
suggests that scheme (A) or (B) may be possible for EmrE, depending on whether the competing 
ligand is a +2 or +1 compound, respectively.  There is no support for scheme (C), a scheme that 
allows for the simultaneous binding of two protons and one drug molecule.
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Figure 3.  Transport by EmrE is electroneutral.  Transport is not electrogenic for either a +1 or +2 
charged ligand, under the conditions of the assay.  EmrE (26 µM) was reconstituted into 20 
mg/mL POPE/POPG 3:1 (wt/wt) liposomes.  The pH of the bulk solution was monitored over 
time.  A pH gradient was introduced across the liposome between the weakly buffered exterior 
solution (1 mM KPi, 300 mM KCl, pH ~7.6) and the strongly buffered interior volume (20 mM 
KPi, 300 mM KCl, pH 6) by addition of base.  The affect of the order of addition on transport 
was tested by adding: (i) ~40 µM ligand, 1 µg/mL valinomycin, ~40 µM ligand, and 1 µg/mL 
FCCP (blue traces) or (ii) 1 µg/mL valinomycin, ~40 µM ligand, ~40 µM ligand, and 1 µg/mL 
FCCP (red traces) for both PP2+ (A) and TPP+ (B).  Black circles mark each addition.  For both 
substrates, transport was initiated by the addition of ligand, independent of whether the 
K+-ionophore valinomycin was present.  Pre-incubation with an 8-fold excess of the carbodi-
imide DCCD over protein greatly inhibits transport (green traces, compounds added according to 
(i)), indicating that this assay is monitoring transport by EmrE.  The addition of the protonophore 
FCCP demonstrates that a pH gradient was held across the liposomes.
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